Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
14000,,18582782,CHEMBL4222950,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
14001,,18582810,CHEMBL4222951,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14002,,18663126,CHEMBL4232541,Dark toxicity against human MCF7 cells assessed as decrease in cell viability by MTT assay,T,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4229395,Bioorg Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3099497,=,1,1,=,IC50,nM,13800.0,CHEMBL612558,,ADMET,,,IC50,uM,UO_0000065,13.8
14003,,18688140,CHEMBL4252692,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14004,,18688181,CHEMBL4252693,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14005,,18688222,CHEMBL4252694,Antibacterial activity against Bacillus subtilis after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
14006,,18688263,CHEMBL4252695,Antibacterial activity against Micrococcus luteus ATCC4698 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,1.0
14007,,18688304,CHEMBL4252696,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC,ug ml-1,UO_0000274,4.0
14008,,18688345,CHEMBL4252697,Antibacterial activity against Escherichia coli DH52 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14009,,18688386,CHEMBL4252698,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
14010,,18688427,CHEMBL4252699,Antibacterial activity against Bacillus typhi after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,1.0
14011,,18688468,CHEMBL4252700,Antibacterial activity against Escherichia coli JM109 after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14012,,18688509,CHEMBL4252701,Antibacterial activity against Shigella dysenteriae after 24 hrs by micro broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,ug ml-1,UO_0000274,16.0
14013,Not Active,18688741,CHEMBL4252710,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 16 serial passages by two-fold serial dilution assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251572,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3104064,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14014,,18690705,CHEMBL4253109,Antibacterial activity against Staphylococcus epidermidis after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
14015,,18690708,CHEMBL4253108,Antibacterial activity against Staphylococcus aureus ATCC 6538P after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14016,,18690725,CHEMBL4253102,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.02
14017,,18693142,CHEMBL4253347,Antibacterial activity against Flavobacterium columnare FC-G1 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,MIC,nM,32000.0,CHEMBL4296571,Flavobacterium columnare,Flavobacterium columnare,996.0,,MIC,uM,UO_0000065,32.0
14018,,18693183,CHEMBL4253348,Antibacterial activity against Escherichia coli ATCC 35150 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,MIC,nM,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,1.0
14019,,18693219,CHEMBL4253349,Antibacterial activity against Streptococcus agalactiae WB1445 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,MIC,nM,64000.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,uM,UO_0000065,64.0
14020,,18693260,CHEMBL4253350,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,MIC,nM,32000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,32.0
14021,,18693296,CHEMBL4253351,Bactericidal activity against Flavobacterium columnare FC-G1 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,MBC,uM,128.0,CHEMBL4296571,Flavobacterium columnare,Flavobacterium columnare,996.0,,MBC,uM,UO_0000064,128.0
14022,,18693337,CHEMBL4253352,Bactericidal activity against Escherichia coli ATCC 35150 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,MBC,uM,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,uM,UO_0000064,2.0
14023,,18693373,CHEMBL4253353,Bactericidal activity against Streptococcus agalactiae WB1445 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,MBC,uM,128.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MBC,uM,UO_0000064,128.0
14024,,18693414,CHEMBL4253354,Bactericidal activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251599,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,MBC,uM,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,64.0
14025,Active,18705475,CHEMBL4255881,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two-fold serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251702,ACS Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3106613,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14026,Active,18705498,CHEMBL4255879,Antimicrobial activity against Enterococcus faecalis after 24 hrs by two-fold serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251702,ACS Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3106613,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
14027,Active,18705597,CHEMBL4255887,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by two-fold serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251702,ACS Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3106613,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
14028,,18705603,CHEMBL4255891,Antimicrobial activity against Enterococcus faecalis assessed as ratio of MIC after and before 7 serial passages measured at 24 hrs interval for 16 days by two-fold serial dilution method,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4251702,ACS Med Chem Lett,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3106613,=,1,0,=,Ratio,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Ratio,,,16.0
14029,,18730825,CHEMBL4260148,Antibacterial activity against methicillin resistant Staphylococcus aureus after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14030,,18730844,CHEMBL4260149,Antibacterial activity against Staphylococcus aureus after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14031,,18730863,CHEMBL4260150,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14032,,18730882,CHEMBL4260151,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14033,,18730901,CHEMBL4260152,Antibacterial activity against Enterococcus faecalis after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14034,,18730920,CHEMBL4260153,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14035,,18730939,CHEMBL4260154,Antibacterial activity against Escherichia coli after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14036,,18730958,CHEMBL4260155,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14037,,18730977,CHEMBL4260156,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14038,,18730996,CHEMBL4260157,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14039,,18731015,CHEMBL4260158,Antibacterial activity against Acinetobacter baumannii after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4257553,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14040,,18740099,CHEMBL4262098,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,4.0
14041,,18740117,CHEMBL4262099,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,4.0
14042,,18740140,CHEMBL4262097,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14043,,18740158,CHEMBL4262096,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14044,,18740185,CHEMBL4262100,Antibacterial activity against Escherichia coli JM109 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14045,,18740203,CHEMBL4262101,Antibacterial activity against Escherichia coli DH52 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14046,,18740221,CHEMBL4262102,Antibacterial activity against Shigella dysenteriae after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,ug ml-1,UO_0000274,4.0
14047,,18740239,CHEMBL4262103,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
14048,,18740256,CHEMBL4262104,Antibacterial activity against Proteus vulgaris ATCC 13315 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,8.0
14049,,18740273,CHEMBL4262105,Antibacterial activity against Bacillus typhi after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,4.0
14050,Not Active,18740310,CHEMBL4262118,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 5 passages,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4261494,Medchemcomm,2017.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3113446,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14051,,18788050,CHEMBL4272164,Antibacterial activity against Staphylococcus aureus after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14052,,18788062,CHEMBL4272165,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14053,,18788074,CHEMBL4272166,Antibacterial activity against Enterococcus faecalis after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14054,,18788086,CHEMBL4272167,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14055,,18788098,CHEMBL4272168,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14056,,18788110,CHEMBL4272169,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14057,,18788122,CHEMBL4272170,Antibacterial activity against Escherichia coli after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14058,,18788134,CHEMBL4272171,Antibacterial activity against Acinetobacter baumannii after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14059,,18788146,CHEMBL4272172,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14060,,18788158,CHEMBL4272173,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14061,,18788170,CHEMBL4272174,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by micro broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4270534,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14062,,18829048,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4303101,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3135546,=,52,1,=,Inhibition,%,6.88,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,6.88
14063,,18853877,CHEMBL4306905,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by two fold serial dilution,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.13
14064,,18853878,CHEMBL4306909,Antibacterial activity against Bacillus subtilis PTCC 1023 after 18 hrs by two fold serial dilution,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.13
14065,,18853879,CHEMBL4306910,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs by two fold serial dilution,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.13
14066,,18853880,CHEMBL4306911,Antibacterial activity against Escherichia coli ATCC 8739 after 18 hrs by two fold serial dilution,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
14067,,18853881,CHEMBL4306913,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by two fold serial dilution,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.13
14068,,18853882,CHEMBL4306931,Antibacterial activity against Escherichia coli infected in mouse,F,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3147014,=,1,1,=,ED50,mg.kg-1,5.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,5.6
14069,,18853883,CHEMBL4306949,Antibacterial activity against Enterococcus faecalis after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,13.0
14070,,18853884,CHEMBL4306950,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,13.0
14071,,18853885,CHEMBL4306951,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,13.0
14072,,18853886,CHEMBL4306952,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,13.0
14073,,18853887,CHEMBL4306953,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,13.0
14074,,18853888,CHEMBL4306954,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,13.0
14075,,18853889,CHEMBL4306955,Antibacterial activity against Acinetobacter baumannii after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,13.0
14076,,18853890,CHEMBL4306956,Antibacterial activity against Escherichia coli after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,13.0
14077,,18853891,CHEMBL4306957,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,13.0
14078,,18853892,CHEMBL4306958,Antibacterial activity against Klebsiella pneumoniae after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,13.0
14079,,18853893,CHEMBL4306959,Antibacterial activity against drug-resistant Escherichia coli after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,MIC,nM,100000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,100.0
14080,,18882731,CHEMBL4312434,Antibacterial activity against Staphylococcus aureus 11011 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.0
14081,,18882737,CHEMBL4312433,Antibacterial activity against Pseudomonas aeruginosa 25349 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.0
14082,,18882770,CHEMBL4312424,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.0
14083,,18882805,CHEMBL4312429,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,1000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,1.0
14084,,18882829,CHEMBL4312430,Antibacterial activity against Escherichia coli 20411 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,62.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.0625
14085,,18882853,CHEMBL4312431,Antibacterial activity against Acinetobacter baumannii AB1901 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,>,1,1,>,MIC,nM,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,128.0
14086,,18882880,CHEMBL4312425,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.0
14087,,18882896,CHEMBL4312426,Antibacterial activity against Salmonella enterica serovar typhimurium C77-31 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,250.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,0.25
14088,,18882961,CHEMBL4312428,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,125.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.125
14089,,18882996,CHEMBL4312427,Antibacterial activity against Escherichia coli UB1005 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.0
14090,,18883048,CHEMBL4312432,Antibacterial activity against Acinetobacter baumannii AB1902 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,>,1,1,>,MIC,nM,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,128.0
14091,,18883312,CHEMBL4312490,Antibacterial activity against ciprofloxacin-resistant Escherichia coli ATCC 25922 incubated for 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,MIC,nM,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,1.0
14092,,18883322,CHEMBL4312491,"Resistance index, ratio of MIC for antibacterial activity against ciprofloxacin-resistant Escherichia coli to MIC for Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method",F,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4311942,J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3150910,=,1,0,=,Ratio,,4.0,CHEMBL612545,,Unchecked,,,Ratio,,,4.0
14093,,18911675,CHEMBL4321117,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14094,,18911707,CHEMBL4321118,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14095,,18911739,CHEMBL4321119,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14096,,18911771,CHEMBL4321120,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14097,,18934627,CHEMBL4326746,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14098,,18934630,CHEMBL4326745,Antibacterial activity against Staphylococcus aureus 1199B,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14099,,18934633,CHEMBL4326744,Antibacterial activity against Staphylococcus aureus 1199-3,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14100,,18934636,CHEMBL4326743,Antibacterial activity against Staphylococcus aureus 1199,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14101,,18962782,CHEMBL4334803,Antibacterial activity against Staphylococcus aureus FDA 209P at sub-MIC by resistant development assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4334431,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3163885,=,1,1,=,MIC,nM,800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.8
14102,,18962783,CHEMBL4334802,Antimicrobial activity against carbapenem-resistant Escherichia coli K12 W3110 at sub-MIC treated by resistant development assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4334431,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3163885,=,1,1,=,MIC,nM,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.2
14103,,19001128,CHEMBL4343521,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14104,,19001129,CHEMBL4343522,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
14105,,19001130,CHEMBL4343523,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,1.0
14106,,19001131,CHEMBL4343524,Antimicrobial activity against Escherichia coli JM 109 after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14107,,19001132,CHEMBL4343525,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
14108,,19001133,CHEMBL4343526,Antimicrobial activity against Shigella dysenteriae after 24 hrs by two-fold broth serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,ug ml-1,UO_0000274,1.0
14109,,19001134,CHEMBL4343527,Antifungal activity against Candida albicans ATCC 76615 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,1.0
14110,,19001135,CHEMBL4343528,Antifungal activity against Candida utilis after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,MIC,ug ml-1,UO_0000274,1.0
14111,,19001136,CHEMBL4343529,Antifungal activity against Aspergillus flavus after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,MIC,ug ml-1,UO_0000274,1.0
14112,,19001137,CHEMBL4343530,Antifungal activity against Saccharomyces cerevisiae after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,ug ml-1,UO_0000274,1.0
14113,,19001138,CHEMBL4343531,Antifungal activity against Candida mycoderma after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,MIC,ug.mL-1,1.0,CHEMBL613254,Pichia norvegensis,Pichia norvegensis,4921.0,,MIC,ug ml-1,UO_0000274,1.0
14114,,19027705,CHEMBL4348801,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14115,,19027735,CHEMBL4348802,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14116,,19027765,CHEMBL4348803,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14117,,19027795,CHEMBL4348804,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14118,,19030409,CHEMBL4349287,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,14.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,14.1
14119,,19030467,CHEMBL4349291,Antifungal activity against Candida albicans,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,7.8
14120,,19030484,CHEMBL4349293,Antifungal activity against Aspergillus niger,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,10.2,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,ug ml-1,UO_0000274,10.2
14121,,19030726,CHEMBL4349315,Antibacterial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,31.0
14122,,19030735,CHEMBL4349316,Antibacterial activity against Bacillus anthracis incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,31.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,31.0
14123,,19030738,CHEMBL4349317,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,MIC,ug.mL-1,11.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,11.7
14124,,19047780,CHEMBL4354114,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14125,,19047798,CHEMBL4354115,Antibacterial activity against Enterococcus faecalis assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.013
14126,,19047816,CHEMBL4354116,Antibacterial activity against Staphylococcus aureus assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.006
14127,,19047834,CHEMBL4354117,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.003
14128,,19047852,CHEMBL4354118,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.003
14129,,19047870,CHEMBL4354119,Antibacterial activity against Klebsiella pneumoniae assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mM,UO_0000065,0.013
14130,,19047888,CHEMBL4354120,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.05
14131,,19047906,CHEMBL4354121,Antibacterial activity against Escherichia coli assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.025
14132,,19047924,CHEMBL4354122,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,6000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.006
14133,,19047942,CHEMBL4354123,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.002
14134,,19047960,CHEMBL4354124,Antibacterial activity against Acinetobacter baumannii assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,MIC,nM,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.025
14135,,19048055,CHEMBL4354132,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as fold change after 16 serial passages at 0.5 times of MIC incubated for 12 hrs by sequential passaging method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351006,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3177663,=,1,0,=,FC,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,16.0
14136,,19050416,CHEMBL4354624,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14137,,19050436,CHEMBL4354625,Antibacterial activity against Enterococcus faecalis incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14138,,19050456,CHEMBL4354626,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14139,,19050476,CHEMBL4354627,Antibacterial activity against Klebsiella pneumoniae incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14140,,19050496,CHEMBL4354628,Antibacterial activity against Escherichia coli incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14141,,19050516,CHEMBL4354629,Antibacterial activity against Pseudomonas aeruginosa incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14142,,19050536,CHEMBL4354630,Antibacterial activity against Acinetobacter baumannii incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14143,Active,19050571,CHEMBL4354655,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 at 0.5 times MIC measured after 6 to 16 passages,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4351025,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3178146,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14144,,19051580,CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,mg/L,UO_0000274,2.0
14145,,19051594,CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,mg/L,UO_0000274,0.12
14146,,19051616,CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612535,Klebsiella,Klebsiella,570.0,,MIC90,mg/L,UO_0000274,0.5
14147,,19051630,CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,mg/L,UO_0000274,64.0
14148,,19051644,CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,mg/L,UO_0000274,0.06
14149,,19051658,CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,1.0
14150,,19051672,CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,16.0
14151,,19051686,CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,mg/L,UO_0000274,4.0
14152,,19051700,CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,mg/L,UO_0000274,4.0
14153,Not Determined,19051714,CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3178412,,1,0,,MIC90,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,,,
14154,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051724,CHEMBL4354987,"Cmax in human at 0.4 g, po bid",A,BAO_0002119,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3178412,=,1,1,=,Cmax,nM,4697.19,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,1.5
14155,,19051726,CHEMBL4354988,"AUC in human at 0.4 g, po bid",A,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3178412,=,1,1,=,AUC,ng.hr.mL-1,10000.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,10.0
14156,,19051728,CHEMBL4354989,"Half life in human at 0.4 g, po bid",A,BAO_0002115,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Hour,3178412,=,1,1,=,T1/2,hr,3.0,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,3.0
14157,,19071416,CHEMBL4361780,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14158,,19071451,CHEMBL4361781,Antibacterial activity against methicillin resistant Staphylococcus aureus N 315 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14159,,19071486,CHEMBL4361782,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
14160,,19071521,CHEMBL4361783,Antibacterial activity against Bacillus proteus ATCC 8427 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,2.0
14161,,19071556,CHEMBL4361784,Antibacterial activity against Escherichia coli JM109 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14162,,19071591,CHEMBL4361774,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359852,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14163,Not Determined,19073451,CHEMBL4362173,Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 7 days by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3182227,,1,0,,IC50,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,,,
14164,Not Determined,19073461,CHEMBL4362172,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-334 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3182227,,1,0,,IC50,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,,,
14165,Not Determined,19073473,CHEMBL4362171,Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3182227,,1,0,,IC50,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,,,
14166,,19073479,CHEMBL4362167,Antibacterial activity against Escherichia coli ATCC 8739 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3182227,>,1,1,>,IC50,nM,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,0.25
14167,,19073490,CHEMBL4362168,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3182227,>,1,1,>,IC50,nM,500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,uM,UO_0000065,0.5
14168,Not Determined,19073501,CHEMBL4362169,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3182227,,1,0,,IC50,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IC50,,,
14169,Not Determined,19073512,CHEMBL4362170,Antibacterial activity against Enterococcus faecium ATCC 19434 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3182227,,1,0,,IC50,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,IC50,,,
14170,,19106299,CHEMBL4369603,Antimicrobial activity against Staphylococcus aureus 209p measured every 24 hrs for 5 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,7.5
14171,,19106324,CHEMBL4369604,Antimicrobial activity against Bacillus cereus ATCC 8035 measured every 24 hrs for 5 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,25000.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,25.0
14172,,19106349,CHEMBL4369605,Antimicrobial activity against Escherichia coli CDC F-50 measured every 24 hrs for 5 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.7
14173,,19106374,CHEMBL4369606,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 measured every 24 hrs for 5 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,9400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,9.4
14174,,19106469,CHEMBL4369610,Bactericidal activity against Staphylococcus aureus 209p measured after 4 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,7.5
14175,,19106493,CHEMBL4369611,Bactericidal activity against Bacillus cereus ATCC 8035 measured after 4 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,50000.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,50.0
14176,,19106517,CHEMBL4369612,Bactericidal activity against Escherichia coli CDC F-50 measured after 4 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.7
14177,,19106541,CHEMBL4369613,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 measured after 4 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4368886,Medchemcomm,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,MIC,nM,48800.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,48.8
14178,,19164364,CHEMBL4384013,Antibacterial activity against Proteus vulgaris after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198398,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,62.5
14179,,19164476,CHEMBL4384033,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,IZ,mm,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,19.0
14180,,19164479,CHEMBL4384034,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,IZ,mm,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,19.0
14181,,19164482,CHEMBL4384035,Antibacterial activity against Escherichia coli MTCC 443 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,IZ,mm,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,19.0
14182,,19164485,CHEMBL4384036,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,IZ,mm,19.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,19.0
14183,,19165347,CHEMBL4384114,Antibacterial activity against methicillin-resistant Staphylococcus aureus after overnight incubation by micro broth dilution analysis,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,MIC99,ug ml-1,0.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC99,ug ml-1,UO_0000274,0.61
14184,,19165432,CHEMBL4384115,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis after overnight incubation by micro broth dilution analysis,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,MIC99,ug ml-1,0.73,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC99,ug ml-1,UO_0000274,0.73
14185,,19165517,CHEMBL4384116,Antibacterial activity against methicillin-resistant Staphylococcus haemolyticus after overnight incubation by micro broth dilution analysis,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,MIC99,ug ml-1,0.58,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC99,ug ml-1,UO_0000274,0.58
14186,,19166004,CHEMBL4384132,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,IZ,mm,10.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,10.04
14187,,19166006,CHEMBL4384133,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,IZ,mm,9.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IZ,mm,UO_0000016,9.07
14188,,19166008,CHEMBL4384134,Antibacterial activity against methicillin-resistant Staphylococcus haemolyticus assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,IZ,mm,12.71,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,IZ,mm,UO_0000016,12.71
14189,Active,19166047,CHEMBL4384137,Antibiofilm activity against methicillin-resistant Staphylococcus aureus at 2 times MIC after 24 hrs by crystal violet staining-based UV-visible spectrophotometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3198680,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14190,,19166144,CHEMBL4384155,Antibacterial activity against Escherichia coli NCTC 10418 infected in po dosed CF mouse measured after 1 week,F,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3198685,=,1,1,=,ED50,mg.kg-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,6.0
14191,,19237681,CHEMBL4399097,Antibacterial activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14192,,19237704,CHEMBL4399098,Bactericidal activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.25
14193,,19237728,CHEMBL4399099,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14194,,19237751,CHEMBL4399100,Bactericidal activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.0
14195,,19237775,CHEMBL4399101,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
14196,,19237798,CHEMBL4399102,Bactericidal activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,2.0
14197,,19237822,CHEMBL4399103,Antibacterial activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,64.0
14198,,19237841,CHEMBL4399104,Bactericidal activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,64.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MBC,ug ml-1,UO_0000274,64.0
14199,,19237857,CHEMBL4399105,Antibacterial activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.125
14200,,19237880,CHEMBL4399106,Bactericidal activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MBC,ug ml-1,UO_0000274,0.125
14201,,19237904,CHEMBL4399107,Antibacterial activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
14202,,19237927,CHEMBL4399108,Bactericidal activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.063
14203,,19237951,CHEMBL4399109,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14204,,19237974,CHEMBL4399110,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.25
14205,,19237998,CHEMBL4399111,Antibacterial activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.016
14206,,19238022,CHEMBL4399112,Bactericidal activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MBC,ug ml-1,UO_0000274,0.016
14207,,19238046,CHEMBL4399113,Antibacterial activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14208,,19238069,CHEMBL4399114,Bactericidal activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
14209,,19238093,CHEMBL4399115,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
14210,,19238116,CHEMBL4399116,Bactericidal activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.125
14211,,19238140,CHEMBL4399117,Antibacterial activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
14212,,19238158,CHEMBL4399118,Bactericidal activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,>,1,0,>,MBC,ug ml-1,512.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,512.0
14213,,19238178,CHEMBL4399119,Antibacterial activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.25
14214,,19238201,CHEMBL4399120,Bactericidal activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MBC,ug ml-1,UO_0000274,0.25
14215,,19247100,CHEMBL4400925,Antibacterial activity against Streptococcus pyogenes CMCC 32067 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,>,1,1,>,MIC,nM,401250.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,umol/L,UO_0000065,401.25
14216,,19247141,CHEMBL4400924,Antibacterial activity against Staphylococcus aureus CMCC 25923 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.39
14217,,19247182,CHEMBL4400923,Antibacterial activity against Staphylococcus aureus CMCC(B) 26003 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.39
14218,,19247229,CHEMBL4400928,Antibacterial activity against Bacillus subtilis CMCC 63501 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,6270.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,umol/L,UO_0000065,6.27
14219,,19247269,CHEMBL4400927,Antibacterial activity against Enterococcus faecalis CMCC 29212 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,3130.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,umol/L,UO_0000065,3.13
14220,,19247310,CHEMBL4400926,Antibacterial activity against Streptococcus pneumoniae CMCC 31968 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,>,1,1,>,MIC,nM,401250.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,umol/L,UO_0000065,401.25
14221,,19247354,CHEMBL4400929,Antibacterial activity against Escherichia coli CMCC 25922 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,390.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,0.39
14222,,19247395,CHEMBL4400930,Antibacterial activity against Escherichia coli CMCC 44568 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,390.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,0.39
14223,,19247436,CHEMBL4400931,Antibacterial activity against Pseudomonas aeruginosa CMCC 27853 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,6270.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,6.27
14224,,19247477,CHEMBL4400932,Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,12540.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,12.54
14225,,19247488,CHEMBL4400933,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,1570.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,1.57
14226,,19247499,CHEMBL4400934,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,780.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.78
14227,,19247510,CHEMBL4400935,Antibacterial activity against multidrug-resistant Escherichia coli ATCC BAA-196 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,1570.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,1.57
14228,,19247521,CHEMBL4400936,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2111 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,MIC,nM,3130.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,3.13
14229,,19247525,CHEMBL4400937,Antibacterial activity against Staphylococcus aureus CMCC 25923 assessed as ratio of MIC after and before 16 passages at sub-MIC,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3213108,=,1,0,=,Ratio,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,32.0
14230,,19247527,CHEMBL4400938,Antibacterial activity against Escherichia coli CMCC 44568 assessed as ratio of MIC after and before 16 passages at sub-MIC,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3213108,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
14231,,19428180,CHEMBL4428439,Antimicrobial activity against Eberthella typhosa ATCC 14028 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,4.0
14232,,19428194,CHEMBL4428440,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14233,,19428208,CHEMBL4428442,Antimicrobial activity against Bacillus proteus ATCC13315 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL4296593,Proteus hauseri,Proteus hauseri,183417.0,,MIC,ug ml-1,UO_0000274,4.0
14234,,19428222,CHEMBL4428441,Antimicrobial activity against Escherichia coli JM109 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14235,,19428236,CHEMBL4428443,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14236,,19428250,CHEMBL4428444,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14237,,19428264,CHEMBL4428445,Antimicrobial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
14238,,19428278,CHEMBL4428446,Antimicrobial activity against Micrococcus luteus ATCC 4698 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,2.0
14239,Not Determined,19428292,CHEMBL4428447,Antimicrobial activity against Candida utilis ATCC 9950 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3245236,,1,0,,MIC80,,,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,MIC80,,,
14240,Not Determined,19428306,CHEMBL4428448,Antimicrobial activity against Aspergillus flavus ATCC 204304 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3245236,,1,0,,MIC80,,,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,MIC80,,,
14241,Not Determined,19428320,CHEMBL4428449,Antimicrobial activity against beer yeast ATCC 9763 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3245236,,1,0,,MIC80,,,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC80,,,
14242,Not Determined,19428334,CHEMBL4428450,Antimicrobial activity against Candida albicans ATCC 76615 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3245236,,1,0,,MIC80,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC80,,,
14243,Not Determined,19428348,CHEMBL4428451,Antimicrobial activity against Candida mycoderma ATCC 9888 incubated for 24 hrs by NCCLS protocol based method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3245236,,1,0,,MIC80,,,CHEMBL612545,,Unchecked,,,MIC80,,,
14244,,19436727,CHEMBL4430638,Antibacterial activity against multidrug resistant Escherichia coli 1137 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428104,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3246700,=,1,1,=,MIC,ug.mL-1,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.25
14245,,19436728,CHEMBL4430637,Antibacterial activity against methicillin resistant Staphylococcus aureus 3089 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4428104,Bioorg Med Chem Lett,2016.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3246700,>,1,1,>,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
14246,,19486628,CHEMBL4481665,Antimicrobial activity against penicillin-resistant Staphylococcus aureus ATCC 29213 assessed as ratio of MIC after and before 15 serial passages preincubated followed by replating and measured after 24 hrs,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3258825,=,1,0,=,Ratio,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,500.0
14247,,19956676,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495564,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3343094,=,52,1,=,Inhibition,%,34.2,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,34.2
14248,,19960167,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495564,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3346585,=,52,1,=,Inhibition,%,21.69,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,21.68565005
14249,,20149329,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495565,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3360966,=,52,1,=,Inhibition,%,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.15
14250,,20150691,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495565,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3364457,=,52,1,=,Inhibition,%,-0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.08
14251,Median N= 2; Maxinhib 4.8 Pct,20166430,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,MIC,nM,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,10.0
14252,Median N= 2; Maxinhib 6.5 Pct,20166431,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,MIC,nM,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,10.0
14253,Median N= 2,20166432,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,MIC,nM,625.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.625
14254,Median N= 2; Range >10 - 10  Um,20166433,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,MIC,nM,10000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,10.0
14255,Median N= 2; Maxinhib 11.8 Pct,20166434,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,MIC,nM,10000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,10.0
14256,Median N= 2,20166435,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,MIC,nM,5000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,5.0
14257,Median N= 2,20166436,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4513141,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,MIC,nM,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,5.0
14258,,20612327,CHEMBL4606424,"Resistance index, ratio of MIC for antibacterial activity against Staphylococcus aureus ATCC 29213 passed over 19 cycles in presence of compound for period of 15 consecutive days by broth microdilution method to MIC for antibacterial activity against Staphylococcus aureus ATCC 29213",F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4602730,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3467606,=,1,0,=,Ratio,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,128.0
14259,,20640488,CHEMBL4612952,Induction of Escherichia coli K12 MG1655 recA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4610120,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3473710,=,1,0,=,FC,,20.0,CHEMBL3434,Escherichia coli K-12,Recombinase A,83333.0,,FC,,,20.0
14260,,20640495,CHEMBL4612953,Induction of Escherichia coli K12 MG1655 lexA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4610120,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3473710,=,1,0,=,FC,,5.0,CHEMBL4630871,Escherichia coli,LexA repressor,562.0,,FC,,,5.0
14261,,20640502,CHEMBL4612954,Induction of Escherichia coli K12 MG1655 recN promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4610120,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3473710,=,1,0,=,FC,,14.0,CHEMBL4630870,Escherichia coli,DNA repair protein RecN,562.0,,FC,,,14.0
14262,,20640509,CHEMBL4612955,Induction of Escherichia coli K12 MG1655 sulA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4610120,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3473710,=,1,0,=,FC,,17.0,CHEMBL1287594,Escherichia coli K-12,Cell division inhibitor sulA,83333.0,,FC,,,17.0
14263,,20642006,CHEMBL4613438,In vivo antibacterial activity against Escherichia coli infected in po dosed mouse,F,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3474073,=,1,1,=,ED50,mg.kg-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,6.0
14264,,20703239,CHEMBL4627783,Antibacterial activity against methicillin-resistant Staphylococcus aureus by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14265,,20703253,CHEMBL4627784,Antibacterial activity against Staphylococcus aureus by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14266,,20703267,CHEMBL4627785,Antibacterial activity against Staphylococcus aureus ATCC 25923 by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14267,,20703281,CHEMBL4627786,Antibacterial activity against Enterococcus faecalis by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14268,,20703295,CHEMBL4627787,Antibacterial activity against Klebsiella pneumoniae by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14269,,20703309,CHEMBL4627788,Antibacterial activity against Escherichia coli by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14270,,20703323,CHEMBL4627789,Antibacterial activity against Escherichia coli ATCC 25922 by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14271,,20703337,CHEMBL4627790,Antibacterial activity against Pseudomonas aeruginosa by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14272,,20703351,CHEMBL4627791,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14273,,20703365,CHEMBL4627792,Antibacterial activity against Acinetobacter baumannii by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14274,Not Active,20703371,CHEMBL4627799,Antibacterial activity against Enterococcus faecalis measured after 16 passages by microbroth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3486700,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
14275,,20703402,CHEMBL4627805,Antibacterial activity against Staphylococcus aureus ATCC 29213 by two fold serial microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14276,,22072456,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495565,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3360966,=,52,1,=,Inhibition,%,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.15
14277,,22075947,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4495565,,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3364457,=,52,1,=,Inhibition,%,-0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.08
14278,No. Measurements = 1,22083594,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4651402,,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3491118,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
14279,No. Measurements = 1,22083595,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4651402,,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3491118,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
14280,Not Active,22386697,CHEMBL4666206,Antibacterial activity against Klebsiella pneumoniae measured every 24 hrs after several passages by serial dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3507134,,1,0,,Activity,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,,,
14281,,22386711,CHEMBL4666210,Inhibition of Escherichia coli DNA gyrase holoenzyme assessed as reduction in pBR322 DNA supercoiling using pBR322 plasmid DNA as substrate incubated for 90 mins in presence of ATP by ethidium bromide staining based agarose gel electrophoresis analysis,B,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,IC50,nM,18600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,18.6
14282,,22386742,CHEMBL4666211,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,6000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.006
14283,,22386928,CHEMBL4666217,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.025
14284,,22386959,CHEMBL4666218,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.002
14285,,22386990,CHEMBL4666219,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.025
14286,,22387021,CHEMBL4666220,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.05
14287,,22387053,CHEMBL4666221,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mM,UO_0000065,0.013
14288,,22387085,CHEMBL4666222,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.006
14289,,22387116,CHEMBL4666223,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.003
14290,,22387147,CHEMBL4666224,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.002
14291,,22387179,CHEMBL4666225,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.013
14292,,22387210,CHEMBL4666226,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4665627,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14293,,22424805,CHEMBL4674722,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4673214,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514143,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14294,,22424823,CHEMBL4674725,Resistance ratio of compound MIC for Staphylococcus aureus ATCC 29213 after 20 passages to compound MIC for Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by CLSI-based broth microdilution method,F,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4673214,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3514143,=,1,0,=,Ratio,,256.0,CHEMBL612545,,Unchecked,,,Ratio,,,256.0
14295,,22434304,CHEMBL4677249,Antibacterial activity against Staphylococcus aureus SA-1199B,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4673276,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3515518,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14296,Not Active,22455652,CHEMBL4681933,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing by measuring reduction in bacterial colony count at 64 times MIC incubated for 2 hrs by time-kill kinetics method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680106,J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3519433,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14297,,22455661,CHEMBL4681941,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 grown under presence of test compound at 1/2 MIC assessed as inhibition of bacterial growth measured after 14 passages by broth microdilution method relative to wild type,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680106,J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3519433,>,1,0,>,Ratio,,80.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,80.0
14298,,22464189,CHEMBL4683670,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 43300 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,IZ,mm,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,25.0
14299,,22464199,CHEMBL4683671,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 33591 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,IZ,mm,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,26.0
14300,,22464209,CHEMBL4683672,Antibacterial activity against multidrug resistant Escherichia coli ATCC BAA-196 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,IZ,mm,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,27.0
14301,,22464219,CHEMBL4683673,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa ATCC BAA-2111 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,IZ,mm,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,24.0
14302,,22464229,CHEMBL4683674,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 43300 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,MIC,ug.mL-1,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.25
14303,,22464239,CHEMBL4683675,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 33591 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
14304,,22464249,CHEMBL4683676,Antibacterial activity against multidrug resistant Escherichia coli ATCC BAA-196 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,MIC,ug.mL-1,1.57,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.57
14305,,22464259,CHEMBL4683677,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa ATCC BAA-2111 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.13
14306,,22464269,CHEMBL4683678,Bactericidal activity against Staphylococcus aureus ATCC 43300 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,MBC,ug ml-1,2.81,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.81
14307,,22464279,CHEMBL4683679,Bactericidal activity against Staphylococcus aureus ATCC 33591 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,MBC,ug ml-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.56
14308,,22464289,CHEMBL4683680,Bactericidal activity against Escherichia coli ATCC BAA-196 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,MBC,ug ml-1,3.53,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,3.53
14309,,22464299,CHEMBL4683681,Bactericidal activity against Pseudomonas aeruginosa ATCC BAA-2111 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4680155,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,MBC,ug ml-1,4.69,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,4.69
14310,,22755076,CHEMBL4700631,Antibacterial activity against Bacillus subtilis assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,IZ,mm,2.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,2.5
14311,,22755090,CHEMBL4700632,Antibacterial activity against Staphylococcus aureus assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,IZ,mm,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,2.5
14312,,22755104,CHEMBL4700633,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,IZ,mm,2.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,2.5
14313,,22755118,CHEMBL4700634,Antibacterial activity against Escherichia coli assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,IZ,mm,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,2.5
14314,,22755975,CHEMBL4700719,Antibacterial activity against Klebsiella pneumoniae MTCC 618 incubated for 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532120,=,1,1,=,MIC,ug.mL-1,9.375,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,9.375
14315,,22760774,CHEMBL4702016,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as ratio of MIC after and before 13 serial passages,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4699493,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3533170,=,1,0,=,Ratio,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,22.0
14316,,22886463,CHEMBL4728207,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as ratio of MIC after and before 10 serial passages at 0.5 times MIC passaged daily for 10 days,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4725344,J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3552146,=,1,0,=,Ratio,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,128.0
14317,,22903632,CHEMBL4732609,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14318,,22903650,CHEMBL4732610,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
14319,,22903668,CHEMBL4732611,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14320,,22903686,CHEMBL4732612,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14321,,22903704,CHEMBL4732613,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14322,,22903722,CHEMBL4732614,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14323,,22903740,CHEMBL4732615,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14324,,22903758,CHEMBL4732616,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14325,,22903776,CHEMBL4732617,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
14326,,22903794,CHEMBL4732618,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14327,,22903812,CHEMBL4732619,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732030,RSC Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.5
14328,,22922223,CHEMBL4736873,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,10.0
14329,,22922243,CHEMBL4736874,Antibacterial activity against Escherichia coli MTCC 443 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
14330,,22922263,CHEMBL4736875,Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
14331,,22922317,CHEMBL4736878,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,10.0
14332,,22961617,CHEMBL4768925,Antibacterial activity against methicillin-resistant Staphylococcus aureus N. 315,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14333,,22961680,CHEMBL4768928,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14334,,22961701,CHEMBL4768929,Antibacterial activity against Bacillus subtilis ATCC 6633,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,4.0
14335,,22961722,CHEMBL4768930,Antibacterial activity against Campylobacter coli JM 109,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC,ug ml-1,UO_0000274,8.0
14336,,22961743,CHEMBL4768931,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
14337,,22961764,CHEMBL4768932,Antibacterial activity against Bacillus proteus ATCC 8427,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765291,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,2.0
14338,,22963644,CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,MIC,ug.mL-1,1250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1250.0
14339,,22963645,CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,MIC,nM,3914446.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3914.446
14340,,22963728,CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,MIC,ug.mL-1,625.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,625.0
14341,,22963729,CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,MIC,nM,1957223.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,uM,UO_0000065,1957.223
14342,,22963810,CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,MIC,ug.mL-1,2.4,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,2.4
14343,,22963811,CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,MIC,nM,7516000.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,7516.0
14344,,22963896,CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,MIC,ug.mL-1,4.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.8
14345,,22963897,CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765295,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,MIC,nM,15031000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,15031.0
14346,,22975751,CHEMBL4771719,Antimicrobial activity against Escherichia coli NCTC 11954 producing penicillinase assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,24400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.0244
14347,,22975760,CHEMBL4771720,Antimicrobial activity against Escherichia coli ATCC 8739 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,48900.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.0489
14348,,22975771,CHEMBL4771721,Antimicrobial activity against Escherichia coli O157:H7 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,MIC,nM,5900.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.0059
14349,,22975780,CHEMBL4771722,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,293700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.2937
14350,,22975788,CHEMBL4771723,Antimicrobial activity against Salmonella enterica ATCC 13312 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,MIC,nM,5900.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,mM,UO_0000065,0.0059
14351,,22975797,CHEMBL4771724,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9627 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,98000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.098
14352,,22975805,CHEMBL4771725,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,24400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.0244
14353,,22975814,CHEMBL4771726,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 9253 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,24400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.0244
14354,,22975823,CHEMBL4771727,Antimicrobial activity against Listeria monocytogenes ATCC 19115 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,MIC,nM,5900.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,mM,UO_0000065,0.0059
14355,,22975832,CHEMBL4771728,Antifungal activity against Candida albicans ATCC 10231 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,MIC,nM,5900.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,mM,UO_0000065,0.0059
14356,,22975843,CHEMBL4771729,Antifungal activity against Aspergillus flavus ATCC 9643 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,782900.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,MIC,mM,UO_0000065,0.7829
14357,,22975854,CHEMBL4771730,Antifungal activity against Fusarium solani ATCC 36031 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,391400.0,CHEMBL612506,Fusarium solani,Fusarium solani,169388.0,,MIC,mM,UO_0000065,0.3914
14358,,22975864,CHEMBL4771731,Antifungal activity against Stachybotrys chartarum IBT 7711 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,195700.0,CHEMBL613284,Stachybotrys chartarum,Stachybotrys chartarum,74722.0,,MIC,mM,UO_0000065,0.1957
14359,,22975874,CHEMBL4771732,Antifungal activity against Penicillium chrysogenum ATCC 10106 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,MIC,nM,195700.0,CHEMBL612847,Penicillium chrysogenum,Penicillium chrysogenum,5076.0,,MIC,mM,UO_0000065,0.1957
14360,,22975884,CHEMBL4771733,Cytotoxicity against rat L6 cells assessed as inhibition of cell viability incubated for 24 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4765367,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,IC50,nM,3431.1,CHEMBL614793,Rattus norvegicus,L6,10116.0,,IC50,uM,UO_0000065,3.4311
14361,,23172245,CHEMBL4814646,Antibacterial activity against Escherichia coli by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813920,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,MIC,nM,1605000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,1.605
14362,,23172247,CHEMBL4814647,Antibacterial activity against Enterococcus faecalis by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813920,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,MIC,nM,803000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.8029999999999999
14363,,23172249,CHEMBL4814648,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813920,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,MIC,nM,1605000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,1.605
14364,,23172251,CHEMBL4814649,Antibacterial activity against Acinetobacter baumannii by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813920,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,MIC,nM,803000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.8029999999999999
14365,,23182519,CHEMBL4816900,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14366,,23182541,CHEMBL4816901,Antibacterial activity against Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14367,,23182563,CHEMBL4816902,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14368,,23182585,CHEMBL4816903,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14369,,23182607,CHEMBL4816904,Antibacterial activity against Enterococcus faecalis assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14370,,23182629,CHEMBL4816905,Antibacterial activity against Klebsiella pneumonia assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14371,,23182651,CHEMBL4816906,Antibacterial activity against Acinetobacter baumannii assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
14372,,23182673,CHEMBL4816907,Antibacterial activity against Escherichia coli assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14373,,23182695,CHEMBL4816908,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14374,,23182717,CHEMBL4816909,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14375,,23182739,CHEMBL4816910,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in microbial growth by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4813987,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
14376,,23188179,CHEMBL4818005,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14377,,23188196,CHEMBL4818006,Antibacterial activity against Enterococcus faecalis by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
14378,,23188213,CHEMBL4818007,Antibacterial activity against Staphylococcus aureus by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14379,,23188230,CHEMBL4818008,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14380,,23188247,CHEMBL4818009,Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14381,,23188264,CHEMBL4818010,Antibacterial activity against Klebsiella pneumonia by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
14382,,23188281,CHEMBL4818011,Antibacterial activity against Escherichia coli by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14383,,23188298,CHEMBL4818012,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14384,,23188315,CHEMBL4818013,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14385,,23188332,CHEMBL4818014,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
14386,,23188349,CHEMBL4818015,Antibacterial activity against Acinetobacter baumannii by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14387,Not Active,23188353,CHEMBL4818017,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth measured after 16 passages,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3605760,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14388,,23189663,CHEMBL4818352,Antibacterial activity against methicillin resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14389,,23189684,CHEMBL4818353,Antibacterial activity against Enterococcus faecalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14390,,23189705,CHEMBL4818354,Antibacterial activity against Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14391,,23189726,CHEMBL4818355,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14392,,23189747,CHEMBL4818356,Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14393,,23189768,CHEMBL4818357,Antibacterial activity against Klebsiella pneumonia by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14394,,23189789,CHEMBL4818358,Antibacterial activity against Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14395,,23189810,CHEMBL4818359,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14396,,23189831,CHEMBL4818360,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14397,,23189852,CHEMBL4818361,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14398,,23189873,CHEMBL4818362,Antibacterial activity against Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14399,Not Active,23189880,CHEMBL4818368,Antibacterial activity against Escherichia coli ATCC 25922 measured after 6 passages by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3606158,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
14400,,23214442,CHEMBL4823061,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14401,,23214466,CHEMBL4823062,Antibacterial activity against Enterococcus faecalis assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,256.0
14402,,23214490,CHEMBL4823063,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14403,,23214514,CHEMBL4823064,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14404,,23214538,CHEMBL4823065,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14405,,23214562,CHEMBL4823066,Antibacterial activity against Klebsiella pneumonia assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
14406,,23214586,CHEMBL4823067,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
14407,,23214610,CHEMBL4823068,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
14408,,23214634,CHEMBL4823069,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14409,,23214658,CHEMBL4823070,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
14410,,23214682,CHEMBL4823071,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
14411,Not Active,23214689,CHEMBL4823076,Antibacterial activity against methicillin-resistant Staphylococcus aureus measured after 13 passages by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3610555,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14412,,23220348,CHEMBL4824557,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14413,,23220363,CHEMBL4824558,Antibacterial activity against Enterococcus faecalis by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,25000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.025
14414,,23220378,CHEMBL4824559,Antibacterial activity against Staphylococcus aureus by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.006
14415,,23220393,CHEMBL4824560,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.003
14416,,23220408,CHEMBL4824561,Antibacterial activity against Staphylococcus aureus ATCC 29213 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.006
14417,,23220423,CHEMBL4824562,Antibacterial activity against Klebsiella pneumonia by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mM,UO_0000065,0.013
14418,,23220438,CHEMBL4824563,Antibacterial activity against Escherichia coli by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.05
14419,,23220453,CHEMBL4824564,Antibacterial activity against Pseudomonas aeruginosa by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,25000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.025
14420,,23220468,CHEMBL4824565,Antibacterial activity against Acinetobacter baumannii by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.025
14421,,23220483,CHEMBL4824566,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,3000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.003
14422,,23220498,CHEMBL4824567,Antibacterial activity against Escherichia coli ATCC 25922 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,MIC,nM,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.025
14423,,23220511,CHEMBL4824580,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3611638,=,1,0,=,MIC,10^-3mM,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,10^-3mM,,0.7809999999999999
14424,,23220512,CHEMBL4824581,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Enterococcus faecalis assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3611638,=,1,0,=,MIC,10^-3mM,0.781,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,10^-3mM,,0.7809999999999999
14425,,23220513,CHEMBL4824582,Potentiation of(Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Klebsiella pneumoniae assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3611638,=,1,0,=,MIC,10^-3mM,0.203,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,10^-3mM,,0.203
14426,,23220514,CHEMBL4824583,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Escherichia coli assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4823277,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3611638,=,1,0,=,MIC,10^-3mM,0.781,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,10^-3mM,,0.7809999999999999
14427,,23235882,CHEMBL4828077,Antibacterial activity against wild-type Staphylococcus aureus SA-1199 incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4825750,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3614641,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14428,,23235884,CHEMBL4828078,Antibacterial activity against Staphylococcus aureus SA-1199B overexpressing NorA incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4825750,Bioorg Med Chem Lett,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3614641,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
14429,,23241096,CHEMBL4829245,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14430,,23241136,CHEMBL4829246,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
14431,,23241179,CHEMBL4829247,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 62202 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14432,,23241219,CHEMBL4829248,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 52056 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14433,,23241259,CHEMBL4829249,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC513045 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
14434,,23241299,CHEMBL4829250,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC515992 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
14435,,23241339,CHEMBL4829251,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49800 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14436,,23241379,CHEMBL4829252,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49025 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14437,,23241419,CHEMBL4829253,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48073 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14438,,23241459,CHEMBL4829254,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48966 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14439,,23241499,CHEMBL4829255,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49008 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14440,,23241539,CHEMBL4829256,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48706 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14441,,23241579,CHEMBL4829257,Antibacterial activity against Escherichia coli ATCC25922 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
14442,,23241619,CHEMBL4829258,Antibacterial activity against Pseudomonas aeruginosa ATCC27853 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
14443,,23241659,CHEMBL4829259,Antibacterial activity against Enterococcus faecalis ATCC29212 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL4828717,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
14444,Not Determined,24350825,CHEMBL5032114,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3772642,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
14445,Not Determined,24350832,CHEMBL5032115,Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3772642,,1,0,,MIC,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,,,
14446,,24350839,CHEMBL5032116,Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,MIC,nM,150.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,0.15
14447,,24350846,CHEMBL5032117,Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA-427 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,MIC,nM,1220.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.22
14448,,24350865,CHEMBL5032124,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,MIC,nM,1220.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.22
14449,Not Determined,24350872,CHEMBL5032125,Antimicrobial activity against methicilin- resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3772642,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
14450,,24350879,CHEMBL5032126,Antimicrobial activity against multidrug-resistant Staphylococcus aureus ATCC BAA-44 assessed as inhibition of bacterial growth by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5030557,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,MIC,nM,2440.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.44
14451,,24374427,CHEMBL5036802,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14452,,24374456,CHEMBL5036803,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14453,,24374485,CHEMBL5036804,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14454,,24374514,CHEMBL5036805,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14455,,24374543,CHEMBL5036806,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14456,,24374572,CHEMBL5036807,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
14457,,24374601,CHEMBL5036808,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14458,,24374630,CHEMBL5036809,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14459,,24374659,CHEMBL5036810,Antibacterial activity against Acinetobacter baumanii assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
14460,,24374688,CHEMBL5036811,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14461,,24374717,CHEMBL5036812,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
14462,,24374762,CHEMBL5036830,Antibacterial activity against Escherichia coli assessed as drug resistance by measuring fold change in MIC treated for 16 serial passages and measured every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3776167,=,1,0,=,FC,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,32.0
14463,,24374763,CHEMBL5036831,Antibacterial activity against Pseudomonas aeruginosa assessed as drug resistance by measuring fold change in MIC treated for 16 serial passages and measured every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036317,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3776167,=,1,0,=,FC,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,32.0
14464,Active,24377782,CHEMBL5037689,Induction of drug resistance in Staphylococcus aureus ATCC29213 assessed as reduction in bacterial growth at 0.5 times MIC measured after 24 hr,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5036339,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3776624,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14465,,24391944,CHEMBL5041482,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14466,,24391970,CHEMBL5041483,Antibacterial activity against Enterococcus faecalis assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,6000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.006
14467,,24391996,CHEMBL5041484,Antibacterial activity against Staphylococcus aureus assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.002
14468,,24392022,CHEMBL5041485,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.013
14469,,24392048,CHEMBL5041486,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.1
14470,,24392074,CHEMBL5041487,Antibacterial activity against Klebsiella pneumoniae assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,6000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mM,UO_0000065,0.006
14471,,24392100,CHEMBL5041488,Antibacterial activity against Escherichia coli assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.013
14472,,24392126,CHEMBL5041489,Antibacterial activity against Pseudomonas aeruginosa assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,25000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.025
14473,,24392152,CHEMBL5041490,Antibacterial activity against Acinetobacter baumannii assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,6000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.006
14474,,24392178,CHEMBL5041491,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,200000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.2
14475,,24392204,CHEMBL5041492,Antibacterial activity against Escherichia coli ATCC 25922 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,MIC,nM,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.013
14476,,24392248,CHEMBL5041502,Induction of bacterial resistance in Escherichia coli assessed as fold increase in MIC measured after 16 days by resistance development assay,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5038640,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3779183,=,1,0,=,FC,,64.0,CHEMBL612545,,Unchecked,,,FC,,,64.0
14477,Not Active,24400049,CHEMBL5043610,Antibacterial activity against methicillin resistant Staphylococcus aureus treated over 10 serial passages measured after 24 hrs by resistance development assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3780926,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14478,,24400059,CHEMBL5043611,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14479,,24400089,CHEMBL5043612,Antibacterial activity against Enterococcus faecium assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
14480,,24400119,CHEMBL5043613,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14481,,24400149,CHEMBL5043614,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14482,,24400179,CHEMBL5043615,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14483,,24400209,CHEMBL5043616,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14484,,24400238,CHEMBL5043617,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
14485,,24400267,CHEMBL5043618,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14486,,24400296,CHEMBL5043619,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
14487,,24400325,CHEMBL5043620,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14488,,24400354,CHEMBL5043621,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14489,,24400416,CHEMBL5043639,Binding affinity to Staphylococcus aureus PBP2a measured after 6 hrs by ELISA,B,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5042496,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,0,=,Activity,ug ml-1,7.67,CHEMBL612545,,Unchecked,,,Activity,ug ml-1,UO_0000274,7.67
14490,,24513086,CHEMBL5056331,Antimicrobial activity against Pseudomonas aeruginosa PA01 assessed as inhibition of microbial growth measured after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5055634,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3838216,=,1,1,=,MIC,ug.mL-1,4.16,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.16
14491,,24513115,CHEMBL5056333,Cytotoxicity against human WH1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5055634,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3838216,=,1,1,=,IC50,nM,14070.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,14.07
14492,,24513200,CHEMBL5056348,"Resistance index, ratio of IC50 for antitumor activity against human MCF7 cells to IC50 for antitumour activity against dox resistant human MCF7/ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay",F,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5055634,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3838216,=,1,0,=,Ratio IC50,,1.0,CHEMBL612545,,Unchecked,,,Ratio IC50,,,1.0
14493,,24690717,CHEMBL5105660,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14494,,24690736,CHEMBL5105661,Antibacterial activity against Enterococcus faecalis assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14495,,24690755,CHEMBL5105662,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14496,,24690774,CHEMBL5105663,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14497,,24690793,CHEMBL5105664,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14498,,24690812,CHEMBL5105665,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14499,,24690831,CHEMBL5105666,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14500,,24690850,CHEMBL5105667,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14501,,24690869,CHEMBL5105668,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14502,,24690888,CHEMBL5105669,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14503,,24690907,CHEMBL5105670,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
14504,,24690948,CHEMBL5105684,Induction of drug resistance in Enterococcus faecalis assessed as fold increase in MIC measured for 16 passages relative to control,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3849820,=,1,0,=,FC,,7.0,CHEMBL612545,,Unchecked,,,FC,,,7.0
14505,Active,24702808,CHEMBL5107856,Effect on DNA damage repair in Caulobacter vibrioides expressing Gam-GFP reporter system assessed as increase in double stranded break by measuring Gam localization in cells at 25 to 50 ug/ml and measured after 2 hrs by fluorescence analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104228,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3851949,,1,0,,Activity,,,CHEMBL612285,Caulobacter vibrioides,Caulobacter vibrioides,155892.0,,Activity,,,
14506,Active,24702822,CHEMBL5107862,Effect on DNA damage repair in Caulobacter vibrioides lacking uvrA expression assessed as decrease in cell survival rate upto 1 ug/ml and measured after 2 days by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5104228,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3851949,,1,0,,Activity,,,CHEMBL612285,Caulobacter vibrioides,Caulobacter vibrioides,155892.0,,Activity,,,
14507,,24713174,CHEMBL5110689,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14508,,24713224,CHEMBL5110690,Antibacterial activity against Enterococcus faecalis measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
14509,,24713274,CHEMBL5110691,Antibacterial activity against Staphylococcus aureus measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14510,,24713324,CHEMBL5110692,Antibacterial activity against Staphylococcus aureus ATCC 25923 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14511,,24713374,CHEMBL5110693,Antibacterial activity against Staphylococcus aureus ATCC 29213 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14512,,24713424,CHEMBL5110694,Antibacterial activity against Klebsiella pneumoniae measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14513,,24713473,CHEMBL5110695,Antibacterial activity against Escherichia coli measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
14514,,24713522,CHEMBL5110696,Antibacterial activity against Pseudomonas aeruginosa measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14515,,24713571,CHEMBL5110697,Antibacterial activity against Acinetobacter baumannii measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
14516,,24713620,CHEMBL5110698,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14517,,24713669,CHEMBL5110699,Antibacterial activity against Escherichia coli ATCC 25922 measured by Muller-Hinton broth based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14518,,24713729,CHEMBL5110705,Antibacterial activity against Staphylococcus aureus assessed as fold increase in MIC measured after 16 passages by resistance development assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3854319,=,1,0,=,FC,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,64.0
14519,,24713732,CHEMBL5110707,Antibacterial activity against Pseudomonas aeruginosa assessed as fold increase in MIC measured after 16 passages by resistance development assay,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108027,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3854319,=,1,0,=,FC,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,128.0
14520,,24721691,CHEMBL5112941,Induction of resistant development in Staphylococcus aureus ATCC 29213 assessed as fold increase in MIC at 0.5 MIC after 12 passages by resistant development assay,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5108078,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3855747,=,1,0,=,FC,,32.0,CHEMBL612545,,Unchecked,,,FC,,,32.0
14521,,24741967,CHEMBL5118045,Antibacterial activity against Staphylococcus aureus ATCC 43300 assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5113489,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3859625,=,1,0,=,FC,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,256.0
14522,,24770356,CHEMBL5126060,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5120961,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864923,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14523,,24770369,CHEMBL5126061,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5120961,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864923,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14524,ND,24770382,CHEMBL5126062,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5120961,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3864923,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
14525,,24802524,CHEMBL5135147,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14526,,24802556,CHEMBL5135149,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14527,,24802587,CHEMBL5135150,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14528,,24802618,CHEMBL5135151,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14529,,24802649,CHEMBL5135152,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14530,,24802680,CHEMBL5135153,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14531,,24802711,CHEMBL5135154,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
14532,,24802742,CHEMBL5135155,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14533,,24802773,CHEMBL5135156,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
14534,,24802804,CHEMBL5135157,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
14535,,24802835,CHEMBL5135158,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
14536,,24802840,CHEMBL5135163,Induction of drug resistance in Acinetobacter baumannii assessed as fold increase in MIC value measured after 14 passage by resistance assay,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5131495,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3871964,=,1,0,=,FC,,16.0,CHEMBL612545,,Unchecked,,,FC,,,16.0
14537,,24838921,CHEMBL5144980,Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
14538,,24838953,CHEMBL5144981,Antibacterial activity against Staphylococcus aureus 1199 measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.56
14539,,24838982,CHEMBL5144982,Antibacterial activity against Staphylococcus aureus K1758 measured after 24 hrs by Muller Hinton broth based MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14540,Active,24839139,CHEMBL5144993,Bactericidal activity against Staphylococcus aureus 1199B at 50 ug/mL by time-kill kinetics assay,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,3879623,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
14541,,24839140,CHEMBL5144994,Bactericidal activity against Staphylococcus aureus 1199B assessed as bacterial count at 3.1 ug/mL measured after 24 hrs by time-kill kinetics assay,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3879623,=,1,0,=,Activity,log10CFU/ml,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,6.0
14542,,24839182,CHEMBL5145018,Up regulation of NorA gene expression in Staphylococcus aureus 1199B at 1.55 ug/ml measured after 2 hrs by qRT-PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3879623,=,1,0,=,FC,,0.076,CHEMBL612545,,Unchecked,,,FC,,,0.076
14543,,24839194,CHEMBL5145026,Bactericidal activity against Staphylococcus aureus 1199B infected in human THP-1 cells assessed as reduction in bacterial count at 0.015 to 8 ug/ml measured after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143555,Bioorg Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3879623,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14544,,24842065,CHEMBL5145753,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
14545,,24842093,CHEMBL5145754,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14546,,24842121,CHEMBL5145755,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14547,,24842149,CHEMBL5145756,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14548,,24842177,CHEMBL5145757,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14549,,24842205,CHEMBL5145758,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14550,,24842233,CHEMBL5145759,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
14551,,24842261,CHEMBL5145760,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14552,,24842289,CHEMBL5145761,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14553,,24842317,CHEMBL5145762,Antibacterial activity against Pseudomonas aeruginosa 27853 assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
14554,,24842345,CHEMBL5145763,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14555,,24842354,CHEMBL5145770,Bactericidal activity against Acinetobacter baumannii assessed as fold increase in MIC value after 16 passages by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3880338,=,1,0,=,FC,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,FC,,,32.0
14556,,24842355,CHEMBL5145771,Bactericidal activity against Klebsiella pneumoniae assessed as fold increase in MIC value after 16 passages by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143590,Eur J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3880338,=,1,0,=,FC,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,FC,,,32.0
14557,,24847204,CHEMBL5146986,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14558,,24847232,CHEMBL5146987,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
14559,,24847260,CHEMBL5146988,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14560,,24847288,CHEMBL5146989,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14561,,24847316,CHEMBL5146990,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14562,,24847344,CHEMBL5146991,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
14563,,24847372,CHEMBL5146992,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14564,,24847400,CHEMBL5146993,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14565,,24847428,CHEMBL5146994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14566,,24847456,CHEMBL5146995,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
14567,,24847466,CHEMBL5147005,Induction of drug resistance in Escherichia coli ATCC 25922 assessed as fold increase in MIC measured after 16 days by CLSI protocol based broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3881343,=,1,0,=,FC,,32.0,CHEMBL612545,,Unchecked,,,FC,,,32.0
14568,,24847467,CHEMBL5147006,Induction of drug resistance in Enterococcus faecalis assessed as fold increase in MIC measured after 16 days by CLSI protocol based broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3881343,=,1,0,=,FC,,32.0,CHEMBL612545,,Unchecked,,,FC,,,32.0
14569,,24866609,CHEMBL5151747,Antibacterial activity against vancomycin resistant Enterococcus incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5149998,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3885471,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,4.0
14570,,24866618,CHEMBL5151749,Antibacterial activity against methicillin resistant Staphylococcus aureus incubated for 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5149998,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3885471,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14571,,24912745,CHEMBL5163877,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14572,,24912781,CHEMBL5163878,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
14573,,24912817,CHEMBL5163879,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14574,,24912853,CHEMBL5163880,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14575,,24912889,CHEMBL5163881,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14576,,24912925,CHEMBL5163882,Antibacterial activity against Klebsiella pneumonia assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
14577,,24912960,CHEMBL5163883,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
14578,,24912995,CHEMBL5163884,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
14579,,24913030,CHEMBL5163885,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
14580,,24913065,CHEMBL5163886,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
14581,,24913100,CHEMBL5163887,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5154842,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,128.0
14582,,24960718,CHEMBL5215624,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC measured after 19 passages by CLSI based broth dilution method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214900,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3899010,=,1,0,=,FC,,32.0,CHEMBL612545,,Unchecked,,,FC,,,32.0
14583,,24961672,CHEMBL5215971,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC incubated for 17 days,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214910,J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3899184,=,1,0,=,FC,,32.0,CHEMBL612545,,Unchecked,,,FC,,,32.0
14584,,24965354,CHEMBL5217013,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.003
14585,,24965367,CHEMBL5217014,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14586,,24965380,CHEMBL5217015,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,6000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mM,UO_0000065,0.006
14587,,24965393,CHEMBL5217016,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.025
14588,,24965406,CHEMBL5217017,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.1
14589,,24965419,CHEMBL5217018,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,25000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mM,UO_0000065,0.025
14590,,24965432,CHEMBL5217019,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.05
14591,,24965445,CHEMBL5217020,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mM,UO_0000065,0.025
14592,,24965458,CHEMBL5217021,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,50000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.05
14593,,24965471,CHEMBL5217022,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,12000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mM,UO_0000065,0.012
14594,,24965484,CHEMBL5217023,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,MIC,nM,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,mM,UO_0000065,0.025
14595,Active,24965540,CHEMBL5217043,Induction of drug resistance in Pseudomonas aeruginosa assessed as reduction in susceptibility measured after 6 passages,F,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3900408,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
14596,,24965541,CHEMBL5217044,Induction of drug resistance in Pseudomonas aeruginosa assessed as fold increase in MIC measured after 11 passages,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3900408,=,1,0,=,FC,,8.0,CHEMBL612545,,Unchecked,,,FC,,,8.0
14597,,24983352,CHEMBL5226740,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14598,,24983356,CHEMBL5226741,Antibacterial activity against Pseudomonas aeruginosa No.010,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
14599,,24983360,CHEMBL5226742,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 025,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
14600,,24983364,CHEMBL5226743,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 034,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
14601,,25002714,CHEMBL5233566,Inhibition of mushroom tyrosinase using L-DOPA as substrate incubated for 20 mins by microplate reader assay,B,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5233214,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911620,=,1,1,=,IC50,ug.mL-1,0.7,CHEMBL3318,Agaricus bisporus,Tyrosinase,5341.0,,IC50,ug ml-1,UO_0000274,0.7
14602,,25005081,CHEMBL5234501,Inhibition of Escherichia coli DNA gyrase,B,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5233247,Eur J Med Chem,2020.0,CHEMBL9,NORFLOXACIN,CHEMBL9,1,http://www.openphacts.org/units/Nanomolar,3912694,=,1,1,=,IC50,nM,18600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,18.6
14603,,25023507,CHEMBL5240095,Drug resistance development in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC measured after 20 passages,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5236632,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3916906,=,1,0,=,FC,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,128.0
14604,Active,25023869,CHEMBL5240134,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as increase in MIC at 0.5 times MIC measured after 2 days by CLSI based microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5236634,J Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,3916967,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
14605,,25030487,CHEMBL5241556,Antimicrobial activity against methicillin resistant Staphylococcus aureus 1 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241069,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14606,,25030496,CHEMBL5241557,Antimicrobial activity against methicillin resistant Staphylococcus aureus 2 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241069,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
14607,,25030505,CHEMBL5241558,Antimicrobial activity against methicillin resistant Staphylococcus aureus 3 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241069,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
14608,,25032518,CHEMBL5242327,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.24
14609,,25032558,CHEMBL5242328,Antibacterial activity against Yersinia pseudotuberculosis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC,ug ml-1,UO_0000274,0.24
14610,,25032626,CHEMBL5242330,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.24
14611,,25032676,CHEMBL5242331,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.24
14612,,25032750,CHEMBL5242333,Antibacterial activity against Enterococcus faecalis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.24
14613,,25032814,CHEMBL5242336,Antibacterial activity against Bacillus cereus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,MIC,ug.mL-1,0.24,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.24
14614,,25032900,CHEMBL5242352,Antibacterial activity against Salmonella typhi,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,=,1,1,=,MIC,ug.mL-1,2.4,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,2.4
14615,,25032914,CHEMBL5242353,Antibacterial activity against Salmonella enteritidis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug ml-1,UO_0000274,0.0625
14616,,25035456,CHEMBL5243128,Antibacterial activity against Staphylococcus aureus assessed as diameter of inhibition zone,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,IZ,mm,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,14.0
14617,,25035469,CHEMBL5243129,Antibacterial activity against Bacillus subtilis assessed as diameter of inhibition zone,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,IZ,mm,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,24.0
14618,,25035480,CHEMBL5243130,Antibacterial activity against Escherichia coli assessed as diameter of inhibition zone,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,IZ,mm,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,20.0
14619,,25035494,CHEMBL5243131,Antibacterial activity against Salmonella typhimurium assessed as diameter of inhibition zone,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,IZ,mm,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,DIZ,mm,UO_0000016,16.0
14620,,25035781,CHEMBL5243225,Antibacterial activity against Salmonella typhimurium MTCC 98 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920816,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,10.0
14621,,25040069,CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,IC50,ug.mL-1,17.8,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,IC50,ug ml-1,UO_0000274,17.8
14622,,25040093,CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,IC50,ug.mL-1,6.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,6.7
14623,,25040119,CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,IC50,ug.mL-1,17.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,17.2
14624,,25040142,CHEMBL5244532,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCC1 measured after 48 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,620000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,620.0
14625,,25040148,CHEMBL5244533,Antimalarial activity against chloroquine-resistant Plasmodium falciparum VNS measured after 48 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,510000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,510.0
14626,,25040158,CHEMBL5244538,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,IC50,ug.mL-1,11.24,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,11.24
14627,,25040161,CHEMBL5244539,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,IC50,ug.mL-1,11.24,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,11.24
14628,,25040163,CHEMBL5244540,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,55300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,55.3
14629,,25040165,CHEMBL5244541,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,74600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,74.6
14630,,25040167,CHEMBL5244542,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Palo Alto,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,54100.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,54.1
14631,,25040169,CHEMBL5244543,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR3,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,58600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,58.6
14632,,25040171,CHEMBL5244544,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Bres1,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,75000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,75.0
14633,,25040174,CHEMBL5244545,Antiplasmodial activity against synchronized Plasmodium falciparum CS2,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,59000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,59.0
14634,,25040177,CHEMBL5244546,Antiplasmodial activity against asynchronous Plasmodium falciparum CS2,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,55000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,55.0
14635,,25040180,CHEMBL5244547,Antiplasmodial activity against synchronized Plasmodium falciparum 3D7,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,55000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,55.0
14636,,25040183,CHEMBL5244548,Antiplasmodial activity against asynchronous Plasmodium falciparum 3D7,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,66000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,66.0
14637,,25040186,CHEMBL5244549,Antiplasmodial activity against synchronized Plasmodium falciparum K1,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,67000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,67.0
14638,,25040189,CHEMBL5244550,Antiplasmodial activity against asynchronous Plasmodium falciparum K1,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,IC50,nM,54000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,54.0
14639,,25040756,CHEMBL5244794,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by two fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3922813,=,1,1,=,MIC,nM,20.89,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,nM,UO_0000065,20.89
14640,,25040769,CHEMBL5244796,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
14641,,25040779,CHEMBL5244798,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 measured after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
14642,,25040784,CHEMBL5244799,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 measured after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
14643,,25040831,CHEMBL5244807,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.016
14644,,25040839,CHEMBL5244808,Bactericidal activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,4.0
14645,,25040897,CHEMBL5244824,Antibacterial activity against Escherichia coli ATCC 700603 assessed as bacterial growth inhibition by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
14646,,25040943,CHEMBL5244826,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.1
14647,,25041060,CHEMBL5244841,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0625
14648,,25041165,CHEMBL5244867,Antibacterial activity against Escherichia coli JM109 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
14649,,25041189,CHEMBL5244873,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar streak dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
14650,,25041205,CHEMBL5244874,Antibacterial activity against Escherichia coli NCDC 134 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
14651,,25041248,CHEMBL5244875,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 hrs by twofold serial dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
14652,,25041268,CHEMBL5244878,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 to 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,MIC,ug.mL-1,0.31,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.31
14653,,25051320,CHEMBL5247440,Antibacterial activity against norfloxacin resistant Staphylococcus aureus 1199B overexpressing NorA assessed as bacterial growth inhibition incubated for 24 hrs by resazurin based microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244281,Bioorg Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3926529,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
14654,,25051413,CHEMBL5247484,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1199B overexpressing NorA gene assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5244281,Bioorg Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3926529,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
14655,,25082597,CHEMBL5256154,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,MIC,nM,12100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,12.1
14656,,25082809,CHEMBL5256218,Antimicrobial activity against Staphylococcus aureus ATCC 6538 P FDA 209P by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,MIC,nM,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,7.5
14657,,25082816,CHEMBL5256219,Antimicrobial activity against Bacillus cereus ATCC 10702 NCTC 8035 by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,MIC,nM,24400.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,24.4
14658,,25082822,CHEMBL5256220,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,MIC,nM,24400.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,24.4
14659,,25082828,CHEMBL5256221,Antimicrobial activity against Escherichia coli ATCC 25922 by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,MIC,nM,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.7
14660,,25082835,CHEMBL5256222,Bactericidal against Staphylococcus aureus ATCC 6538 P FDA 209P by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,MBC,uM,7.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,7.5
14661,,25082839,CHEMBL5256223,Bactericidal activity against Bacillus cereus ATCC 10702 NCTC 8035 by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,MBC,uM,24.4,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MBC,uM,UO_0000064,24.4
14662,,25082845,CHEMBL5256224,Bactericidal activity against Enterococcus faecalis ATCC 29212 by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,MBC,uM,24.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC,uM,UO_0000064,24.4
14663,,25082851,CHEMBL5256225,Bactericidal activity against Escherichia coli ATCC 25922 by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,MBC,uM,24.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,uM,UO_0000064,24.4
14664,,25082853,CHEMBL5256226,Bactericidal against Pseudomonas aeruginosa ATCC 9027 by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5252638,RSC Med Chem,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,MBC,uM,49.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,uM,UO_0000064,49.0
14665,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119602,CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,AC50,uM,UO_0000065,10.0
14666,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120621,CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,AC50,uM,UO_0000065,10.0
14667,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128044,CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
14668,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130612,CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
14669,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174415,CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,AC50,uM,UO_0000065,10.0
14670,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187461,CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL5291721,Nat Commun,2023.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,AC50,nM,10000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,10.0
14671,,37906,CHEMBL873322,Antibacterial activity against Klebsiella ozaenae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0381,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.0381
14672,,37907,CHEMBL700135,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.0095
14673,,37908,CHEMBL802305,Antibacterial activity against Shigella sonnei,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,0.0095
14674,,37909,CHEMBL804813,Antibacterial activity against Shigella boydii,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC,ug ml-1,UO_0000274,0.0095
14675,,37910,CHEMBL766966,Antibacterial activity against Plesiomonas shigelloides,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,MIC,ug ml-1,UO_0000274,0.019
14676,,37911,CHEMBL879669,Antibacterial activity against Morganella morganii,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.0095
14677,,37912,CHEMBL809474,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.0095
14678,,37913,CHEMBL770155,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0381,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0381
14679,,37914,CHEMBL813506,Antibacterial activity against Vibrio mimicus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL612621,Vibrio mimicus,Vibrio mimicus,674.0,,MIC,ug ml-1,UO_0000274,0.0095
14680,,37915,CHEMBL813499,Antibacterial activity against Vibrio fluvialis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,MIC,ug ml-1,UO_0000274,0.0095
14681,,37916,CHEMBL816175,Antibacterial activity against Vibrio cholerae 0139,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,0.0095
14682,,37917,CHEMBL816174,Antibacterial activity against Vibrio cholerae 01,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,0.0095
14683,,37918,CHEMBL813512,Antibacterial activity against Vibrio parahaemolyticus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,0.0095
14684,,37919,CHEMBL674714,Antibacterial activity against Escherichia coli NCTC 10418,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.019
14685,,37920,CHEMBL675405,Antibacterial activity against Edwardsiella tarda,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614598,Edwardsiella tarda,Edwardsiella tarda,636.0,,MIC,ug ml-1,UO_0000274,0.0095
14686,,37921,CHEMBL857812,Antibacterial activity against Proteus vulgaris,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.019
14687,,37922,CHEMBL765014,Antibacterial activity against Proteus mirabilis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.0095
14688,,37923,CHEMBL803305,Antibacterial activity against Salmonella Typhimurium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.0095
14689,,37924,CHEMBL801481,Antibacterial activity against Salmonella paratyphi A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.019
14690,,37925,CHEMBL799645,Antibacterial activity against Klebsiella ozaenae Salmonella typhi,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.019
14691,,37926,CHEMBL803218,Antibacterial activity against Salmonella enteritidis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug ml-1,UO_0000274,0.0095
14692,,37927,CHEMBL657688,Antibacterial activity against Citrobacter ferundii,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.0095
14693,,37928,CHEMBL679746,Antibacterial activity against Enterobacter,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.019,CHEMBL614439,Enterobacter,Enterobacter,547.0,,MIC,ug ml-1,UO_0000274,0.019
14694,,37929,CHEMBL649198,Antibacterial activity against Bacillus megatherium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,MIC,ug.mL-1,0.0095,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,0.0095
14695,,54116,CHEMBL688000,Lowest concentration necessary to induce DNA gyrase-mediated cleavage of DNA,B,BAO_0002752,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,0,=,Concentration,ug ml-1,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Concentration,ug ml-1,UO_0000274,0.5
14696,,54117,CHEMBL689081,Concentration required for 50% inhibition of gyrase.,B,BAO_0002752,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,0,=,Concentration,ug ml-1,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Concentration,ug ml-1,UO_0000274,5.3
14697,,54118,CHEMBL677348,Minimum inhibitory concentration against Escherichia coli (H560),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.025
14698,,54119,CHEMBL677349,Minimum inhibitory concentration against Escherichia coli (vogel),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
14699,,54120,CHEMBL700973,Minimum inhibitory concentration against Klebsiella pneumoniae (MGH-2),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.1
14700,,54121,CHEMBL772086,Minimum inhibitory concentration against Providencia rettgeri. (M1771),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.1
14701,,54122,CHEMBL682405,Minimum inhibitory concentration against Enterobacter cloacae. (MA2446).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.05
14702,,54123,CHEMBL763460,Minimum inhibitory concentration against Pseudomonas aeruginosa. (UI-18),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.4
14703,,54124,CHEMBL809590,Minimum inhibitory concentration against Staphylococcus aureus (H-228).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.1
14704,,54125,CHEMBL810411,Minimum inhibitory concentration against Staphylococcus aureus (UC76).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14705,,54126,CHEMBL882117,Minimum inhibitory concentration against Streptococcus faecalis (MGH-2).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.8
14706,,54127,CHEMBL811346,Minimum inhibitory concentration against Streptococcus pneumoniae (SV-1).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.6
14707,,54128,CHEMBL809189,Minimum inhibitory concentration against Streptococcus pyogenes (C203).,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.8
14708,,54129,CHEMBL821621,Minimum inhibitory concentration against gram-negative enterobacteriaceae.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124223,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614439,Enterobacter,Enterobacter,547.0,,MIC,ug ml-1,UO_0000274,0.06
14709,,59554,CHEMBL674723,Antibacterial activity tested against Escherichia coli ATCC 8739,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
14710,,59555,CHEMBL676416,Antibacterial activity tested against Escherichia coli ISF 432,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
14711,,59556,CHEMBL679044,Antibacterial activity tested against Enterobacter cloacae OMNFI 174,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.015
14712,,59557,CHEMBL765244,Antibacterial activity tested against Proteus vulgaris CNUR 5,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.5
14713,,59558,CHEMBL767635,Antibacterial activity tested against Providencia stuartii CNUR 5,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,0.06
14714,,59559,CHEMBL700138,Antibacterial activity tested against Klebsiella pneumoniae (Klebsiella pneumoniae) ATCC 10031,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.015
14715,,59560,CHEMBL804821,Antibacterial activity tested against Shigella enteritidis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614594,Shigella,Shigella,620.0,,MIC,ug ml-1,UO_0000274,0.015
14716,,59561,CHEMBL770158,Antibacterial activity tested against P. ae (Pseudomonas aeruginosa) ATCC 9027,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.06
14717,,59562,CHEMBL808152,Antibacterial activity against Staphylococcus aureus MPR 5,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
14718,,59563,CHEMBL808151,Antibacterial activity against Staphylococcus aureus ATCC 6538,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
14719,,59564,CHEMBL814707,Antibacterial activity tested against Staphylococcus epidermidis HCF Berset C,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
14720,,59565,CHEMBL814706,Antibacterial activity tested against Staphylococcus epidermidis CPHL A2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
14721,,59566,CHEMBL813264,Antibacterial activity tested against Streptococcus faecalis LEP Br,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
14722,,59567,CHEMBL678823,Inhibitory activity against gyrase supercoiling activity from Escherichia coli,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,IC50,ug.mL-1,0.68,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.68
14723,,59569,CHEMBL810747,Antibacterial activity tested against Staphylococcus aureus; Range is 0.13-2 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.13
14724,,59570,CHEMBL808157,Antibacterial activity tested against Staphylococcus aureus Methicillin-and Ciprofloxacin resistants; Range is 4-128 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
14725,,59571,CHEMBL858076,Antibacterial activity tested against Streptococcus pneumoniae; Range is 0.5-2 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
14726,,59572,CHEMBL675459,Antibacterial activity tested against Enterococcus faecalis; Range is 0.5-1 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
14727,,59573,CHEMBL673984,Antibacterial activity tested against Enterococcus faecium; Range is 1-4 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129660,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
14728,,63715,CHEMBL679318,Minimum inhibitory concentration against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1132978,J Med Chem,2000.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16225,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
14729,,79101,CHEMBL806924,Minimum Inhibitory concentration measured against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14730,,79102,CHEMBL812354,Minimum Inhibitory concentration measured against Streptococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
14731,,79103,CHEMBL809201,Minimum Inhibitory concentration measured against Streptococcus pyogenes ATCC 6301,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
14732,,79104,CHEMBL678958,Minimum Inhibitory concentration measured against Escherichia coli ATCC 1-25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
14733,,79105,CHEMBL762961,Minimum Inhibitory concentration measured against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
14734,,79106,CHEMBL651947,Minimum Inhibitory concentration measured against Bacteroides fragilis ATCC 25285,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128580,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153218,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,2.0
14735,,79835,CHEMBL681226,Concentration required to produce linear DNA from closed circular DNA by the denaturation of the drug-gyrase-DNA complex,F,BAO_0002752,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,0,=,Concentration,ug ml-1,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Concentration,ug ml-1,UO_0000274,0.5
14736,,79836,CHEMBL686626,50% inhibitory concentration against DNA-gyrase,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,IC50,ug.mL-1,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,ug ml-1,UO_0000274,5.3
14737,,79837,CHEMBL679145,Antibacterial activity against Escherichia coli H560,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.025
14738,,79838,CHEMBL679152,Antibacterial activity against Escherichia coli Vogel,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
14739,,79839,CHEMBL703087,Antibacterial activity against Klebsiella pneumoniae MGH-2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.1
14740,,79840,CHEMBL767450,Antibacterial activity against Providencia rettgeri M1771,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.1
14741,,79841,CHEMBL679033,Antibacterial activity against Enterobacter cloacae MA2646,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.05
14742,,79842,CHEMBL771958,Antibacterial activity against Pseudomonas aeruginosa UI-18,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.4
14743,,79843,CHEMBL807357,Antibacterial activity against Staphylococcus aureus H-228,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.1
14744,,79844,CHEMBL807195,Antibacterial activity against Staphylococcus aureus UC76,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14745,,79845,CHEMBL813259,Antibacterial activity against Streptococcus faecalis MGH-2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.8
14746,,79846,CHEMBL807987,Antibacterial activity against Streptococcus pneumoniae SV-1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.6
14747,,79847,CHEMBL808693,Antibacterial activity against Streptococcus pyogenes C203,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,287526,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.8
14748,,79848,CHEMBL719159,"Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (po)",F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,287526,=,1,0,=,PD50,mg kg-1,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,PD50,mg kg-1,UO_0000308,1.2
14749,,79849,CHEMBL719160,"Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (sc)",F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124255,J Med Chem,1988.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,287526,=,1,0,=,PD50,mg kg-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,PD50,mg kg-1,UO_0000308,0.3
14750,,82656,CHEMBL635760,Apparent permeability coefficient (Papp) (Caco-2 cell monolayer),A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1134498,J Med Chem,2001.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,99718,=,1,0,=,Papp,cm s-1,1700000.0,CHEMBL612558,,ADMET,,,Papp,cm s-1,,1700000.0
14751,,85890,CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278188,=,1,1,=,IC50,ug.mL-1,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,IC50,ug ml-1,UO_0000274,380.0
14752,,86832,CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,IC50,ug.mL-1,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,IC50,ug ml-1,UO_0000274,380.0
14753,,86833,CHEMBL682682,Antibacterial activity against five Gram-negative bacteria,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.1
14754,,86834,CHEMBL682431,Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB),F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278237,=,1,1,=,MIC,ug.mL-1,0.91,CHEMBL1921666,Staphylococcus aureus,DNA gyrase subunit B,1280.0,,MIC,ug ml-1,UO_0000274,0.91
14755,,96855,CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,IC50,ug.mL-1,380.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,IC50,ug ml-1,UO_0000274,380.0
14756,,96856,CHEMBL682682,Antibacterial activity against five Gram-negative bacteria,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.1
14757,,96857,CHEMBL682431,Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB),F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125556,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278208,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL1921666,Staphylococcus aureus,DNA gyrase subunit B,1280.0,,MIC,ug ml-1,UO_0000274,0.9
14758,,106445,CHEMBL808753,In vitro minimum inhibitory concentration against Staphylococcus aureus CDC1.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
14759,,106446,CHEMBL808755,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 7.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
14760,,106447,CHEMBL808754,In vitro minimum inhibitory concentration against Staphylococcus aureus SN 43.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
14761,,106448,CHEMBL858628,In vitro minimum inhibitory concentration against Staphylococcus aureus COL.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1151495,Bioorg Med Chem Lett,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120737,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
14762,,110126,CHEMBL807015,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus (SA1009 CipR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,MIC,ug.mL-1,32000000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,g ml-1,UO_0000274,32.0
14763,,110127,CHEMBL807352,Antibacterial activity against Staphylococcus aureus (SA1011),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,MIC,ug.mL-1,500000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,g ml-1,UO_0000274,0.5
14764,,110128,CHEMBL808585,Antibacterial activity against linezolid-resistant Staphylococcus aureus (SA1012 LinR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,MIC,ug.mL-1,1000000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,g ml-1,UO_0000274,1.0
14765,,110129,CHEMBL674674,Antibacterial activity against ciprofloxacin resistant Enterococcus faecium (EF4010 CipR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,MIC,ug.mL-1,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,g ml-1,UO_0000274,64.0
14766,,110130,CHEMBL674676,Antibacterial activity against ciprofloxacin resistant and linezolid-resistant Enterococcus faecium (EF4008 LinR;CipR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,MIC,ug.mL-1,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,g ml-1,UO_0000274,64.0
14767,,110131,CHEMBL674675,Antibacterial activity against ciprofloxacin resistant Enterococcus faecium (EF4016 CipR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,MIC,ug.mL-1,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,g ml-1,UO_0000274,64.0
14768,,110132,CHEMBL676494,Antibacterial activity against ciprofloxacin resistant and linezolid-resistant Enterococcus faecium (EF4011 LinR;CipR),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,>,1,1,>,MIC,ug.mL-1,64000000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,g ml-1,UO_0000274,64.0
14769,,110133,CHEMBL692974,Antibacterial activity against Haemophilus influenzae (HI1008),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,<=,1,1,<=,MIC,ug.mL-1,60000.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,g ml-1,UO_0000274,0.06
14770,,110134,CHEMBL731584,Antibacterial activity against Moraxella catarrhalis (MC1002),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,MIC,ug.mL-1,30000.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,g ml-1,UO_0000274,0.03
14771,,110135,CHEMBL678489,Antibacterial activity against Escherichia coli (EC1008 ),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136460,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257530,=,1,1,=,MIC,ug.mL-1,30000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,g ml-1,UO_0000274,0.03
14772,,129581,CHEMBL650967,In vitro minimum inhibitory concentration for Bacillus subtilis ATCC 6633,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.06
14773,,129582,CHEMBL649456,In vitro minimum inhibitory concentration for Bacillus cereus ATCC 11778,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.25
14774,,129583,CHEMBL804606,In vitro minimum inhibitory concentration to inhibit Streptococcus faecalis ATCC 10541,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
14775,,129584,CHEMBL810362,In vitro minimum inhibitory concentration for Staphylococcus aureus ATCC 25178,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14776,,129585,CHEMBL805306,In vitro minimum inhibitory concentration for Staphylococcus epidermidis ATCC 155-1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
14777,,129586,CHEMBL857320,In vitro minimum inhibitory concentration for Pseudomonas aeruginosa ATCC 10145,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
14778,,129587,CHEMBL731863,In vitro minimum inhibitory concentration for Morganella morganii ATCC 8019,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.06
14779,,129588,CHEMBL771727,In vitro minimum inhibitory concentration for Proteus vulgaris ATCC 8427,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.06
14780,,129589,CHEMBL704688,In vitro minimum inhibitory concentration to inhibit Klebsiella pneumoniae ATCC 10031,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
14781,,129590,CHEMBL678999,In vitro minimum inhibitory concentration for Escherichia coli ATCC 10799,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
14782,,129591,CHEMBL679446,In vitro minimum inhibitory concentration for Enterobacter cloacae ATCC 23355,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,257203,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
14783,,129595,CHEMBL619436,AUC (0-4 hr) ug/ml/h,A,BAO_0002120,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127424,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,257203,=,1,1,=,AUC,ng.hr.mL-1,2300.0,CHEMBL612558,,ADMET,,,AUC,ug ml-1 hr-1,,2.3
14784,,136334,CHEMBL671308,In vitro antibacterial activity against Escherichia coli 257,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0078
14785,,136335,CHEMBL672325,In vitro antibacterial activity against Escherichia coli TEM-1 (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0156,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0156
14786,,136336,CHEMBL658712,In vitro antibacterial activity against Citrobacter freundii BS-16 (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0313,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.0313
14787,,136337,CHEMBL705486,In vitro antibacterial activity against Klebsiella pneumoniae A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
14788,,136338,CHEMBL675284,In vitro antibacterial activity against Enterobacter cloacae P99 (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.0078
14789,,136339,CHEMBL805416,In vitro antibacterial activity against Serratia marcescens SM (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0313,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.0313
14790,,136340,CHEMBL767600,In vitro antibacterial activity against Proteus vulgaris ATCC 6380 (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.0078
14791,,136341,CHEMBL754557,In vitro antibacterial activity against Proteus mirabilis 90,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.0625
14792,,136342,CHEMBL764228,In vitro antibacterial activity against Pseudomonas aeruginosa 8780,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14793,,136343,CHEMBL755266,In vitro antibacterial activity against Pseudomonas aeruginosa 18SH (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14794,,136344,CHEMBL812145,In vitro antibacterial activity against Staphylococcus aureus smith,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14795,,136345,CHEMBL801153,In vitro antibacterial activity against Staphylococcus aureus 67(methicillin resistant),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14796,,136346,CHEMBL801155,In vitro antibacterial activity against Staphylococcus aureus 753 (constitutive beta-lactamase producer),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14797,,136347,CHEMBL813032,In vitro antibacterial activity against Streptococcus pneumoniae 6301,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
14798,,136348,CHEMBL804742,In vitro antibacterial activity against Streptococcus pyogenes 4,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
14799,,136349,CHEMBL654069,In vitro antibacterial activity against Bacteroides fragilis S2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,4.0
14800,,136350,CHEMBL647682,In vitro antibacterial activity against Bacteroides fragilis F117A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,16.0
14801,,136351,CHEMBL876578,In vitro antibacterial activity against Bacteroides thetaiotaomicron 62B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,128.0
14802,,136352,CHEMBL656336,In vitro antibacterial activity against Clostridium histolyticum 503-86,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL614966,Hathewaya histolytica,Hathewaya histolytica,1498.0,,MIC,ug ml-1,UO_0000274,0.125
14803,,136353,CHEMBL652968,In vitro antibacterial activity against Clostridium perfringens 13424,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,0.25
14804,,136354,CHEMBL652963,In vitro antibacterial activity against Clostridium difficile 651,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
14805,,136355,CHEMBL876079,In vitro antibacterial activity against Clostridium difficile 701,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
14806,,136356,CHEMBL884459,Effect on replication DNA biosynthesis in Escherichia coli H560 (permeabilised cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,IC50,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.3
14807,,136357,CHEMBL878140,In vitro antibacterial activity against Escherichia coli UB1005 (nalidixic acid-resistant strain),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
14808,,136358,CHEMBL670215,In vitro antibacterial activity against Escherichia coli 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126202,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,90252,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
14809,,139527,CHEMBL806091,Minimum inhibitory concentration against Streptococcus aureus (209P),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
14810,,139528,CHEMBL811536,Minimum inhibitory concentration in vitro against Streptococcus epidermis (56556),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.2
14811,,139529,CHEMBL809197,Minimum inhibitory concentration in vitro against Streptococcus pyogenes (G36),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,1.56
14812,,139530,CHEMBL858061,Minimum inhibitory concentration in vitro against Streptococcus faecalis (ATCC 19433),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.56
14813,,139531,CHEMBL679319,Minimum inhibitory concentration in vitro against Escherichia coli (NIHJ),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
14814,,139532,CHEMBL700982,Minimum inhibitory concentration in vitro against Klebsiella pneumoniae (type-2),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
14815,,139533,CHEMBL772558,Minimum inhibitory concentration in vitro against Proteus vulgaris (08601),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.013
14816,,139534,CHEMBL677360,Minimum inhibitory concentration in vitro against Escherichia cloacae (03400),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.025
14817,,139535,CHEMBL812935,Minimum inhibitory concentration in vitro against Streptococcus marcescens (10100),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.05
14818,,139536,CHEMBL762951,Minimum inhibitory concentration in vitro against Pseudomonas aeruginosa (32104),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127356,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,213668,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.1
14819,,157971,CHEMBL817386,Minimum inhibitory concentration required for primary screening against in-house strain of Streptococcus pneumoniae tested in vitro; Range- 0.2-128,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
14820,,157972,CHEMBL689740,Minimum inhibitory concentration required for primary screening against in-house strain of Haemophilus influenzae tested in vitro; Range- 0.004-1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.015
14821,,157973,CHEMBL730797,Minimum inhibitory concentration required for primary screening against in-house strain of Moraxella catarrhalis tested in vitro; Range- 0.03-0.06,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1137072,Bioorg Med Chem Lett,2004.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307179,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.06
14822,,158734,CHEMBL674214,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1134275,J Med Chem,2001.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.025
14823,,158735,CHEMBL674216,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of ciprofloxacin fluoroquinolone at 16 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1134275,J Med Chem,2001.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.5
14824,,158736,CHEMBL674221,Inhibitory activity against p9- (derivative of ATCC )13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1134275,J Med Chem,2001.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248780,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,32.0
14825,,164675,CHEMBL674579,Tested in vitro for inhibitory activity against gram negative bacteria Escherichia coli ATCC 8739 cell lines at 1 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
14826,,164676,CHEMBL674753,Tested in vitro for inhibitory activity against gram negative bacteria Escherichia coli ISF 432 cell lines at 1 ug/mL,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
14827,,164677,CHEMBL674487,Tested in vitro for inhibitory activity against gram negative bacteria Enterobacter cloacae OMNFI 174 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.01
14828,,164678,CHEMBL636117,Tested in vitro for inhibitory activity against gram negative bacteria Acinetobacter calcoaceticus OSMPV 113 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.06
14829,,164679,CHEMBL858588,Tested in vitro for inhibitory activity against gram negative bacteria Providencia stuartii CNUR 5 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,MIC,ug ml-1,UO_0000274,0.06
14830,,164680,CHEMBL858367,Tested in vitro for inhibitory activity against gram negative bacteria Klebsiella pneumoniae ATCC 10031 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
14831,,164681,CHEMBL804822,Tested in vitro for inhibitory activity against gram negative bacteria Shigella enteritidis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614594,Shigella,Shigella,620.0,,MIC,ug ml-1,UO_0000274,0.03
14832,,164682,CHEMBL858596,Tested in vitro for inhibitory activity against gram negative bacteria Pseudomonas aeruginosa ATCC 9027 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.06
14833,,164683,CHEMBL810562,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus MPR 5 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
14834,,164684,CHEMBL810561,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus ATCC 6538 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
14835,,164685,CHEMBL805358,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis HCF berset C strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
14836,,164686,CHEMBL856962,Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis CPHL A2 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
14837,,164687,CHEMBL812358,Tested in vitro for inhibitory activity against gram positive bacteria Streptococcus faecalis LEP Br strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
14838,,164688,CHEMBL844930,Minimum concentration at which cleaved linear DNA is observed,F,BAO_0002752,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128274,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348008,=,1,0,=,Concentration,ug ml-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Concentration,ug ml-1,UO_0000274,1.0
14839,,169996,CHEMBL798727,In vitro antibacterial activity against Staphylococcus aureus Smith (A9537),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.13
14840,,169997,CHEMBL671304,In vitro antibacterial activity against Escherichia coli (A 15119),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
14841,,169998,CHEMBL702897,In vitro antibacterial activity against Klebsiella pneumoniae (A 9664),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
14842,,169999,CHEMBL674190,In vitro antibacterial activity against Enterobacter cloacae (A 9656),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.008
14843,,170000,CHEMBL706441,In vitro antibacterial activity against Morganella morganii (A 15153),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.015
14844,,170001,CHEMBL754842,In vitro antibacterial activity against Pseudomonas aeruginosa (A 9843),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.13
14845,,170002,CHEMBL798728,In vivo efficacy in systemic infection due to Staphylococcus aureus Smith (A 9537) in mice,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,295235,=,1,0,=,PD50,mg kg-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PD50,mg kg-1,UO_0000308,4.0
14846,,170003,CHEMBL754843,In vivo efficacy in systemic infection due to Pseudomonas aeruginosa (A 9843) in mice,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,295235,=,1,0,=,PD50,mg kg-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,PD50,mg kg-1,UO_0000308,5.0
14847,,170004,CHEMBL671305,In vivo efficacy in systemic infection due to Escherichia coli (A 15119) in mice,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,295235,=,1,0,=,PD50,mg kg-1,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,PD50,mg kg-1,UO_0000308,0.7
14848,,170005,CHEMBL702898,In vivo efficacy in systemic infection due to Klebsiella pneumoniae (A 9664) in mice,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,295235,=,1,0,=,PD50,mg kg-1,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,PD50,mg kg-1,UO_0000308,1.5
14849,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,170007,CHEMBL626035,Maximum concentration in plasma after oral administration in dog (25 mg/kg),A,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,295235,=,1,1,=,Cmax,nM,9053.87,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,Cmax,ug ml-1,UO_0000065,3.0
14850,,170008,CHEMBL636483,Half-life in plasma after oral administration in dog (25 mg/kg),A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,295235,=,1,1,=,T1/2,hr,3.5,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,T1/2,hr,UO_0000032,3.5
14851,,170009,CHEMBL622607,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),A,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1124630,J Med Chem,1989.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295235,=,1,0,=,AUC,ug ml-1,20.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,AUC,ug ml-1,UO_0000274,20.0
14852,,179022,CHEMBL748685,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium fortuitum (clinical isolate) by 50%,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC50,nM,1500.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC50,uM,UO_0000065,1.5
14853,,179023,CHEMBL748687,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium fortuitum (clinical isolate) by 90%,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC90,nM,4000.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC90,uM,UO_0000065,4.0
14854,,179024,CHEMBL748704,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium smegmatis ATCC 19420 by 50%,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC50,nM,8800.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC50,uM,UO_0000065,8.8
14855,,179025,CHEMBL749707,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium smegmatis ATCC 19420 by 90%,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC90,nM,1000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC90,uM,UO_0000065,1.0
14856,,179026,CHEMBL748579,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium avium complex (MAC) ATCC 49601 by 50%,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC50,nM,2000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC50,uM,UO_0000065,2.0
14857,,179027,CHEMBL748582,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium avium complex (MAC) ATCC 49601 by 90%,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC90,nM,3000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC90,uM,UO_0000065,3.0
14858,,179028,CHEMBL749512,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis ATCC 27294 by 50%,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC50,nM,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC50,uM,UO_0000065,1.5
14859,,179029,CHEMBL749683,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis ATCC 27294 by 90%,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC90,nM,3000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,3.0
14860,,179030,CHEMBL749513,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis clinical isolate 1104 by 50%,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC50,nM,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC50,uM,UO_0000065,1.0
14861,,179031,CHEMBL749684,Minimum inhibitory concentration required in vitro to reduce the number of viable of Mycobacterium tuberculosis clinical isolate 1104 by 90%,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC90,nM,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,1.5
14862,,179032,CHEMBL809344,Minimum inhibitory concentration required in vitro against Streptococcus D,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC,nM,400.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,uM,UO_0000065,0.4
14863,,179033,CHEMBL809342,Minimum bactericidal concentration required in vitro against Streptococcus D,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,MBC,uM,0.8,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MBC,uM,UO_0000064,0.8
14864,,179034,CHEMBL809943,Minimum inhibitory concentration required in vitro against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC,nM,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.4
14865,,179035,CHEMBL883384,Minimum bactericidal concentration required in vitro against Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,MBC,uM,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,0.4
14866,,179036,CHEMBL803170,Minimum inhibitory concentration required in vitro against Salmonella,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC,nM,10.0,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,uM,UO_0000065,0.01
14867,,179037,CHEMBL801277,Minimum bactericidal concentration required in vitro against Salmonella,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,MBC,uM,0.01,CHEMBL614446,Salmonella,Salmonella,590.0,,MBC,uM,UO_0000064,0.01
14868,,179038,CHEMBL804812,Minimum inhibitory concentration required in vitro against Shigella,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,72040,=,1,1,=,MIC,nM,10.0,CHEMBL614594,Shigella,Shigella,620.0,,MIC,uM,UO_0000065,0.01
14869,,179039,CHEMBL804810,Minimum bactericidal concentration required in vitro against Shigella,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1131748,Bioorg Med Chem Lett,1999.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,72040,=,1,0,=,MBC,uM,0.01,CHEMBL614594,Shigella,Shigella,620.0,,MBC,uM,UO_0000064,0.01
14870,,206171,CHEMBL858470,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14871,,206172,CHEMBL878428,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
14872,,206173,CHEMBL752157,Antibacterial activity against human Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
14873,,206174,CHEMBL752156,Antibacterial activity against Mycobacterium tuberculosis H331,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
14874,,206175,CHEMBL752155,Antibacterial activity against Mycobacterium tuberculosis H242,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
14875,,206176,CHEMBL752154,Antibacterial activity against Mycobacterium tuberculosis H172,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1136478,Bioorg Med Chem Lett,2003.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,263102,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
14876,,208648,CHEMBL682683,Geometric mean of MIC was determined in vitro against gram-negative strains using standard microtitration techniques,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126729,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,0.05
14877,,208649,CHEMBL682432,Geometric mean of MIC was determined in vitro against gram-positive strains using standard microtitration techniques,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126729,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL612490,Bacteria,Bacteria,2.0,,MIC,ug ml-1,UO_0000274,0.6
14878,,208652,CHEMBL658171,Inhibition of the gyrase mediated cleavage of supercoiled DNA,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1126729,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/MicrogramPerMilliliter,102932,=,1,1,=,IC50,ug.mL-1,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,ug ml-1,UO_0000274,5.3
14879,,211463,CHEMBL672107,"Antibacterial activity against gram negative organism, Escherichia cloacae (MA2646)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.013
14880,,211464,CHEMBL674333,"Antibacterial activity was determined against gram negative organism, E. coli(vogel)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.013
14881,,211465,CHEMBL706025,"Antibacterial activity was determined against gram negative organism, K. pneumoniae (MGH-2)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
14882,,211466,CHEMBL755846,"Antibacterial activity was determined against gram negative organism, Providencia rettgeri. (M1771)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612490,Bacteria,Bacteria,2.0,,MIC,ug ml-1,UO_0000274,0.05
14883,,211467,CHEMBL755262,"Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa (UI-18)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.4
14884,,211468,CHEMBL805136,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (H228)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.6
14885,,211469,CHEMBL805137,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (UC76)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14886,,211470,CHEMBL799852,"Antibacterial activity was determined against gram positive organism, Streptococcus faecalis (MGH-2)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.8
14887,,211471,CHEMBL799744,"Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae (SV-1)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.8
14888,,211472,CHEMBL801924,"Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes (C203)",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18071,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.8
14889,,211478,CHEMBL847744,MIC ratio measured as the mean MICs of gram-negative bacteria,F,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,18071,=,1,0,=,Ratio,,0.044,CHEMBL612545,,Unchecked,,,Ratio,,,0.044
14890,,211479,CHEMBL847746,MIC ratio measured as the mean MICs of gram-positive bacteria,F,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125920,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,18071,=,1,0,=,Ratio,,0.7,CHEMBL612545,,Unchecked,,,Ratio,,,0.7
14891,,218482,CHEMBL808675,In vitro antibacterial activity against Staphylococcus aureus 209P JC-1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
14892,,218483,CHEMBL879522,In vitro antibacterial activity against Micrococcus luteus ATCC 9341,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,1.56
14893,,218484,CHEMBL676903,In vitro antibacterial activity against Escherichia coli NIH JC-2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.0125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0125
14894,,218485,CHEMBL703017,In vitro antibacterial activity against Klebsiella pneumoniae K-1966,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.006
14895,,218486,CHEMBL805413,In vitro antibacterial activity against Serratia marcescens IFO 3736,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.1
14896,,218487,CHEMBL803874,In vitro antibacterial activity against Shigella flexneri 2a EW-10,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.006
14897,,218488,CHEMBL764321,In vitro antibacterial activity against Pseudomonas aeruginosa E-2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125554,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277780,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
14898,,247502,CHEMBL812454,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14899,,247503,CHEMBL810887,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
14900,,247504,CHEMBL804404,In vitro antibacterial activity against Staphylococcus epidermis 3519,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.39
14901,,247505,CHEMBL812911,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.2
14902,,247506,CHEMBL808966,In vitro antibacterial activity against Streptococcus pyogenes 930,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.39
14903,,247507,CHEMBL679386,In vitro antibacterial activity against Escherichia coli Juhl,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.02
14904,,247508,CHEMBL678424,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.05
14905,,247509,CHEMBL700095,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.02
14906,,247510,CHEMBL858595,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.1
14907,,247511,CHEMBL772484,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.1
14908,,247512,CHEMBL857908,In vitro antibacterial activity against Acinetobacter CMX 669,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288275,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,ug ml-1,UO_0000274,1.56
14909,,247513,CHEMBL810293,In vitro mouse protection test against Staphylococcus aureus NCTC 10649 (100 X LD50) (s.c. administration );Range is between (1.0-2.5),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,1.6
14910,,247514,CHEMBL810292,In vitro mouse protection test against Staphylococcus aureus NCTC 10649 (100 X LD50) (p.o. administration );Range is between (9.9-24.1),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,15.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,15.5
14911,,247515,CHEMBL675616,In vitro mouse protection test against Escherichia coli Juhl (100 X LD50) (s.c. administration );Range is between (0.1-0.2),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,0.2
14912,,247516,CHEMBL678378,In vitro mouse protection test against Escherichia coli Juhl (100 X LD50) (p.o. administration );Range is between (1.2-3.0),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,1.9
14913,,247517,CHEMBL764789,In vitro mouse protection test against Pseudomonas aeruginosa 5007 (100 X LD50) (subcutaneous administration; Range is between (1.1-3.8).,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,2.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,ED50,mg kg-1,UO_0000308,2.1
14914,,247518,CHEMBL764791,In vitro mouse protection test against Pseudomonas aeruginosa 5007 (100 X LD50) (p.o. administration ); Range is between (6.8-26.2).,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1123847,J Med Chem,1987.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,288275,=,1,1,=,ED50,mg.kg-1,13.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,ED50,mg kg-1,UO_0000308,13.3
14915,,255377,CHEMBL804630,In vitro minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
14916,,255378,CHEMBL805070,In vitro minimum inhibitory concentration against Staphylococcus aureus CMX 553 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
14917,,255379,CHEMBL805068,In vitro minimum inhibitory concentration against Staphylococcus aureus A 5177 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
14918,,255380,CHEMBL806912,In vitro minimum inhibitory concentration against Staphylococcus aureus NCTC 10649 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.39
14919,,255381,CHEMBL806914,In vitro minimum inhibitory concentration against Staphylococcus epidermidis 3159 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.39
14920,,255382,CHEMBL674277,In vitro minimum inhibitory concentration against Enterococcus faecium ATCC 8043 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.39
14921,,255383,CHEMBL811088,In vitro minimum inhibitory concentration against Streptococcus bovis A5169 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC,ug ml-1,UO_0000274,1.56
14922,,255384,CHEMBL813305,In vitro minimum inhibitory concentration against Streptococcus agalactiae CMX 508 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.39
14923,,255385,CHEMBL813963,In vitro minimum inhibitory concentration against Streptococcus pyogenes 930 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.39
14924,,255386,CHEMBL676895,In vitro minimum inhibitory concentration against Escherichia coli Juhl using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.02
14925,,255387,CHEMBL680772,In vitro minimum inhibitory concentration against Enterobacter aerogenes ATCC 13048 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.05
14926,,255388,CHEMBL703170,In vitro minimum inhibitory concentration against Klebsiella pneumoniae 8045 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.02
14927,,255389,CHEMBL764308,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa A5007 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
14928,,255390,CHEMBL761100,In vitro minimum inhibitory concentration against Pseudomonas aeruginosa K799 / WT using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
14929,,255391,CHEMBL644945,In vitro minimum inhibitory concentration against Acinetobacter CMX 669 using brain-heart infusion agar,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45088,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,MIC,ug ml-1,UO_0000274,0.78
14930,,255392,CHEMBL811371,In vivo antibacterial activity against Staphylococcus aureus NCTC 10649 infected mouse by oral administration,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,45088,=,1,1,=,ED50,mg.kg-1,15.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,15.5
14931,,255393,CHEMBL811372,In vivo antibacterial activity against Staphylococcus aureus NCTC 10649 infected mouse by subcutaneous administration,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125434,J Med Chem,1992.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,45088,=,1,1,=,ED50,mg.kg-1,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,1.6
14932,,269317,CHEMBL673664,In vitro minimum inhibitory concentration was measured against Escherichia coli 257 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
14933,,269318,CHEMBL673666,In vitro minimum inhibitory concentration was measured against Escherichia coli ATCC 25922 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
14934,,269319,CHEMBL673668,In vitro minimum inhibitory concentration was measured against Escherichia coli TEM-1 (Beta lactamase producer) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
14935,,269320,CHEMBL663432,In vitro minimum inhibitory concentration was measured against Citrobacter freundii BS-16 (beta lactamase producer) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.031
14936,,269321,CHEMBL704687,In vitro minimum inhibitory concentration was measured against Klebsiella pneumoniae A strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
14937,,269322,CHEMBL679442,In vitro minimum inhibitory concentration was measured against Enterobacter cloacae 5699 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.016
14938,,269323,CHEMBL679443,In vitro minimum inhibitory concentration was measured against Enterobacter cloacae p99 (beta lactamase producer) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.008
14939,,269324,CHEMBL802091,In vitro minimum inhibitory concentration was measured against Serratia marcescens 1071(beta lactamase producer) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.063
14940,,269325,CHEMBL771726,In vitro minimum inhibitory concentration was measured against Proteus vulgaris 1028BC (beta lactamase producer) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.016
14941,,269326,CHEMBL763279,In vitro minimum inhibitory concentration was measured against Proteus mirabilis 90 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.063
14942,,269327,CHEMBL769410,In vitro minimum inhibitory concentration was measured against Pseudomonas aeruginosa 8780 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14943,,269328,CHEMBL769409,In vitro minimum inhibitory concentration was measured against Pseudomonas aeruginosa 18S/H strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14944,,269329,CHEMBL810763,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus smith strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14945,,269330,CHEMBL810761,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus 67-0 (Methicillin resistant) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14946,,269331,CHEMBL810762,In vitro minimum inhibitory concentration was measured against Staphylococcus aureus 753 (Methicillin resistant) strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14947,,269332,CHEMBL725480,In vitro minimum inhibitory concentration was measured against Micrococcus luteus ATCC 9341 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,2.0
14948,,269333,CHEMBL813978,In vitro minimum inhibitory concentration was measured against Streptococcus pneumoniae 6301 strain,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
14949,,269334,CHEMBL818111,In vitro minimum inhibitory concentration was measured against Streptococcus pyogenes 4 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
14950,,269335,CHEMBL677618,In vitro minimum inhibitory concentration was measured against Enterococcus faecalis ATCC 29212 strain.,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,251200,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
14951,,269336,CHEMBL703074,Tested for its efficacy against systemic murine infection caused by Klebsiella pneumoniae A,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,=,1,1,=,ED50,mg.kg-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,ED50,mg kg-1,UO_0000308,1.0
14952,,269337,CHEMBL878285,Tested for its efficacy against systemic murine infection caused by Enterobacter cloacae 5699.,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,=,1,1,=,ED50,mg.kg-1,0.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,ED50,mg kg-1,UO_0000308,0.2
14953,,269338,CHEMBL810615,Tested for its efficacy against systemic murine infection caused by Serratia marcescens SM.,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,<,1,1,<,ED50,mg.kg-1,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,ED50,mg kg-1,UO_0000308,0.5
14954,,269339,CHEMBL770182,Tested for its efficacy against systemic murine infection caused by Pseudomonas aeruginosa 8780.,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,=,1,1,=,ED50,mg.kg-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,ED50,mg kg-1,UO_0000308,4.0
14955,,269340,CHEMBL814105,Tested for its efficacy against systemic murine infection caused by Staphylococcus aureus smith.,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,=,1,1,=,ED50,mg.kg-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,3.0
14956,,269341,CHEMBL809730,Tested for its efficacy against systemic murine infection caused by Streptococcus pneumoniae 6301.,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127320,J Med Chem,1994.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,251200,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
14957,,295057,CHEMBL678474,Anti-bacterial activity was tested against Gram-negative EC-1 bacterium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
14958,,295058,CHEMBL771949,Anti-bacterial activity tested against Gram-negative PA-7 bacterium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
14959,,295059,CHEMBL807339,Anti-bacterial activity was tested against Gram-positive SA-13 bacterium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.8
14960,,295060,CHEMBL807780,Anti-bacterial activity tested against Gram-positive SP1-1 bacterium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.4
14961,,295061,CHEMBL748677,Anti-bacterial activity tested against Mycobacterium fortuitum (ATCG 6841),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,ug ml-1,UO_0000274,0.06
14962,,295062,CHEMBL752176,Anti-bacterial activity tested against Mycobacterium smegmatis (ATCG 19420),F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1129477,J Med Chem,1996.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320278,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.25
14963,,299228,CHEMBL671309,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli 257,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
14964,,299229,CHEMBL670505,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
14965,,299230,CHEMBL674327,The compound was tested in vitro for minimum inhibitory concentration against Escherichia coli TEM-1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
14966,,299231,CHEMBL660518,The compound was tested in vitro for minimum inhibitory concentration against Citrobacter Freundii BS-16,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.031
14967,,299232,CHEMBL858368,The compound was tested in vitro for minimum inhibitory concentration against Klebsiella pneumoniae A,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
14968,,299233,CHEMBL675287,The compound was tested in vitro for minimum inhibitory concentration against Enterobacter cloacae P99,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.008
14969,,299234,CHEMBL805876,The compound was tested in vitro for minimum inhibitory concentration against Serratia marcescens 1071,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.063
14970,,299235,CHEMBL767598,The compound was tested in vitro for minimum inhibitory concentration against Proteus vulgaris 1028 BC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.016
14971,,299236,CHEMBL754955,The compound was tested in vitro for minimum inhibitory concentration against Proteus mirabilis 90,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.063
14972,,299237,CHEMBL764230,The compound was tested in vitro for minimum inhibitory concentration against Pseudomonas aeruginosa 8780,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14973,,299238,CHEMBL755263,The compound was tested in vitro for minimum inhibitory concentration against Pseudomonas aeruginosa 18S/H,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
14974,,299239,CHEMBL813935,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus smith,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
14975,,299240,CHEMBL800025,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus 67-0,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
14976,,299241,CHEMBL800027,The compound was tested in vitro for minimum inhibitory concentration against Staphylococcus aureus 753,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
14977,,299242,CHEMBL731807,The compound was tested in vitro for minimum inhibitory concentration against Micrococcus luteus ATCC 9341,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,2.0
14978,,299243,CHEMBL813034,The compound was tested in vitro for minimum inhibitory concentration against Streptococcus pneumoniae 6301,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
14979,,299244,CHEMBL802625,The compound was tested in vitro for minimum inhibitory concentration against Streptococcus pyogenes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
14980,,299245,CHEMBL673576,The compound was tested in vitro for minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
14981,,299246,CHEMBL678824,Inhibitory activity on replicative DNA biosynthesis in Escherichia coli H560 (permeabilised cells),F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,IC50,ug.mL-1,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.3
14982,,299247,CHEMBL672326,Minimum inhibitory concentration required to inhibit the activity of Escherichia coli UB1005,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
14983,,299248,CHEMBL670834,Minimum inhibitory concentration required to inhibit the activity of Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,179871,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
14984,,299249,CHEMBL802618,Effective dose against mouse infected with Staphylococcus aureus 753 (MR) (LDs-6),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,179871,=,1,1,=,ED50,mg.kg-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,2.0
14985,,299250,CHEMBL807265,Effective dose against mouse infected with Streptococcus pneumoniae 6301(LDs-5623),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,179871,>,1,1,>,ED50,mg.kg-1,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,50.0
14986,,299251,CHEMBL761062,Effective dose against mouse infected with Pseudomonas aeruginosa 8780 (LDs-240),F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1125212,J Med Chem,1991.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,179871,=,1,1,=,ED50,mg.kg-1,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,ED50,mg kg-1,UO_0000308,3.0
14987,,306191,CHEMBL808062,Tested for minimum inhibitory concentration against Staphylococcus aureus 209P,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
14988,,306192,CHEMBL808063,Tested for minimum inhibitory concentration against Staphylococcus aureus Smith,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
14989,,306193,CHEMBL806934,Tested for minimum inhibitory concentration against Staphylococcus epidermidis 56556,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.2
14990,,306194,CHEMBL812972,Tested for minimum inhibitory concentration against Streptococcus pyogenes G-36,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.78
14991,,306195,CHEMBL680783,Tested for minimum inhibitory concentration against Enterococcus faecalis ATCC 19433,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.78
14992,,306196,CHEMBL682917,Tested for minimum inhibitory concentration against Escherichia coli NIHJ,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
14993,,306197,CHEMBL767452,Tested for minimum inhibitory concentration against Proteus vulgaris 08601,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.05
14994,,306198,CHEMBL858365,Tested for minimum inhibitory concentration against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
14995,,306199,CHEMBL678006,Tested for minimum inhibitory concentration against Enterobacter cloacae 03400,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.05
14996,,306200,CHEMBL763138,Tested for minimum inhibitory concentration against Pseudomonas aeruginosa 32121,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,<=,1,1,<=,MIC,ug.mL-1,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.05
14997,,306201,CHEMBL682916,Tested for minimum inhibitory concentration against Escherichia coli KL-16,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1127078,J Med Chem,1993.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219131,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.025
14998,,319298,CHEMBL682975,In vitro antibacterial activity was tested for Enterobacter cloacae HA2646,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128719,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.05
14999,,319299,CHEMBL682187,In vitro antibacterial activity was tested for Escherichia coli Vogel,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1128719,J Med Chem,1995.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269115,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.05
